{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Medical NER - Knowledge Graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "c:\\Users\\User\\anaconda3\\envs\\NER\\Lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n",
      "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Neo4j database cleared successfully.\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Oral', 'DETAILED_DESCRIPTION'),\n",
      " ('Semaglutide', 'MEDICATION'),\n",
      " ('Renal Impairment', 'DISEASE_DISORDER'),\n",
      " ('6 April', 'DATE'),\n",
      " ('glucagon', 'MEDICATION'),\n",
      " ('-like peptide-1 (GLP-1', 'DETAILED_DESCRIPTION'),\n",
      " ('analogue', 'DETAILED_DESCRIPTION'),\n",
      " ('formulated', 'DETAILED_DESCRIPTION'),\n",
      " ('absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC)',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('sem', 'MEDICATION'),\n",
      " ('normal', 'LAB_VALUE'),\n",
      " ('renal function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('end', 'DETAILED_DESCRIPTION'),\n",
      " ('-stage renal dis- ease', 'DISEASE_DISORDER'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('haemodialysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('once-daily', 'DOSAGE'),\n",
      " ('5 mg', 'DOSAGE'),\n",
      " ('5 days', 'DURATION'),\n",
      " ('10 mg', 'DOSAGE'),\n",
      " ('days', 'DURATION'),\n",
      " ('fasting state', 'DETAILED_DESCRIPTION'),\n",
      " ('30 min', 'DURATION'),\n",
      " ('fasting', 'DETAILED_DESCRIPTION'),\n",
      " ('ARTICLE Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in '\n",
      "  'Subjects with',\n",
      "  'ORG'),\n",
      " ('Thomas W. Anderson 1', 'PERSON'),\n",
      " ('6 April 2018', 'DATE'),\n",
      " ('/C211The Author(s', 'EVENT'),\n",
      " ('2018', 'DATE'),\n",
      " ('Background Semaglutide', 'PERSON'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('11', 'CARDINAL'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('10', 'CARDINAL'),\n",
      " ('30', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'Semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'Renal Impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'Renal Impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '6 April',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': '6 April',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'glucagon',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'glucagon',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-like peptide-1 (GLP-1',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '-like peptide-1 (GLP-1',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'analogue',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'analogue',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'formulated',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'formulated',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) '\n",
      "            'caprylate (SNAC)',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) '\n",
      "            'caprylate (SNAC)',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'sem',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'sem',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'end',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'end',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '-stage renal dis- ease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '-stage renal dis- ease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'haemodialysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'haemodialysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'once-daily',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'once-daily',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '5 mg',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '5 mg',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '5 days',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '5 days',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': '10 mg',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '10 mg',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'days',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'days',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'fasting state',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'fasting state',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '30 min',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '30 min',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'fasting',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'fasting',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ARTICLE Pharmacokinetics, Safety and Tolerability of Oral '\n",
      "            'Semaglutide in Subjects with',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'ARTICLE Pharmacokinetics, Safety and Tolerability of Oral '\n",
      "            'Semaglutide in Subjects with',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Thomas W. Anderson 1',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Thomas W. Anderson 1',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '6 April 2018',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '6 April 2018',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '/C211The Author(s',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '/C211The Author(s',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '2018',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '2018',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Background Semaglutide',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Background Semaglutide',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '11',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '10',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '10',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '30',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 36 nodes and 35 relationships.\n",
      "graph_1.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Blood', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('plasma', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('SNAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('within', 'DATE'),\n",
      " ('first 24 h', 'DURATION'),\n",
      " ('after', 'DATE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('dial', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('day 9', 'DATE'),\n",
      " ('ide', 'DETAILED_DESCRIPTION'),\n",
      " ('Venous blood', 'DETAILED_DESCRIPTION'),\n",
      " ('K 3EDTA tubes', 'DETAILED_DESCRIPTION'),\n",
      " ('- 20 /C176C', 'LAB_VALUE'),\n",
      " ('liquid chromatogra- phy–tandem mass spectroscopy', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('LC–MS/MS)', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('plasma proteins', 'DETAILED_DESCRIPTION'),\n",
      " ('LC– MS/MS', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('.729', 'LAB_VALUE'),\n",
      " ('.8 nmol/L', 'LAB_VALUE'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('half', 'CARDINAL'),\n",
      " ('Plasma Bioanalysis Venous', 'ORG'),\n",
      " ('K 3EDTA', 'GPE'),\n",
      " ('at - 20', 'CARDINAL'),\n",
      " ('Switzerland AG', 'ORG'),\n",
      " ('Fehraltorf', 'GPE'),\n",
      " ('Switzerland', 'GPE')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Blood',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'plasma',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'plasma',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'SNAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'SNAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'within',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'within',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'first 24 h',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'first 24 h',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'dial',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'dial',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'day 9',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'day 9',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'ide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'ide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Venous blood',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'Venous blood',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'K 3EDTA tubes',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'K 3EDTA tubes',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '- 20 /C176C',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '- 20 /C176C',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'liquid chromatogra- phy–tandem mass spectroscopy',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'liquid chromatogra- phy–tandem mass spectroscopy',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'LC–MS/MS)',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'LC–MS/MS)',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'plasma proteins',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'plasma proteins',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'LC– MS/MS',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'LC– MS/MS',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '.729',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '.729',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '.8 nmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '.8 nmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'half',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'half',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Plasma Bioanalysis Venous',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'Plasma Bioanalysis Venous',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'K 3EDTA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'K 3EDTA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'at - 20',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'at - 20',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Switzerland AG',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Switzerland AG',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Fehraltorf',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'Fehraltorf',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Switzerland',\n",
      "  'target_type': 'GPE'}]\n",
      "Graph created with 29 nodes and 28 relationships.\n",
      "graph_2.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('fivefold dilution of each sample', 'DETAILED_DESCRIPTION'),\n",
      " ('60.8 nmol/L', 'LAB_VALUE'),\n",
      " ('A', 'DETAILED_DESCRIPTION'),\n",
      " ('stable isotope-labelled ana- logue of semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('standard', 'DETAILED_DESCRIPTION'),\n",
      " ('AB Sciex API QTrap/C2105500', 'DETAILED_DESCRIPTION'),\n",
      " ('mass', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('spectrometer', 'DETAILED_DESCRIPTION'),\n",
      " ('Positive ions', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('multiple reac- tion-monitoring (MRM) mode', 'DETAILED_DESCRIPTION'),\n",
      " ('mass transitions', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('m/ z 1029.1', 'LAB_VALUE'),\n",
      " ('136.0 Da', 'LAB_VALUE'),\n",
      " ('m', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('/z 1033.2', 'LAB_VALUE'),\n",
      " ('LC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Waters Acquity UPLC/C210system', 'DETAILED_DESCRIPTION'),\n",
      " ('LC column', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Acquity UPLC /C210 BEH300 C18, 2.1 9 50 mm', 'DETAILED_DESCRIPTION'),\n",
      " ('peak area ratios', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('sem', 'DETAILED_DESCRIPTION'),\n",
      " ('aglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('IS', 'DETAILED_DESCRIPTION'),\n",
      " ('calibration curve fitting', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('weighted linear regression (1/concentration2', 'DETAILED_DESCRIPTION'),\n",
      " ('aglut', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('0.729 nmol/L', 'LAB_VALUE'),\n",
      " ('Oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('tablet', 'DOSAGE'),\n",
      " ('5 mg', 'DOSAGE'),\n",
      " ('normal', 'DETAILED_DESCRIPTION'),\n",
      " ('impaired renal', 'DETAILED_DESCRIPTION'),\n",
      " ('function', 'DISEASE_DISORDER'),\n",
      " ('5 days 5 days', 'DATE'),\n",
      " ('Once-daily', 'DETAILED_DESCRIPTION'),\n",
      " ('PK sampling', 'DETAILED_DESCRIPTION'),\n",
      " ('syad 41-0syad 12 Normal', 'DETAILED_DESCRIPTION'),\n",
      " ('-stage renal disease', 'DISEASE_DISORDER'),\n",
      " ('10 mg', 'DOSAGE'),\n",
      " ('Renal', 'DISEASE_DISORDER'),\n",
      " ('.1.2', 'DETAILED_DESCRIPTION'),\n",
      " ('Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (', 'DETAILED_DESCRIPTION'),\n",
      " ('Venous blood', 'DETAILED_DESCRIPTION'),\n",
      " ('K 3EDTA tubes', 'DETAILED_DESCRIPTION'),\n",
      " ('- 20 /C176C', 'LAB_VALUE'),\n",
      " ('60.8', 'CARDINAL'),\n",
      " ('Sciex API QTrap', 'PERSON'),\n",
      " ('Sciex', 'NORP'),\n",
      " ('Framingham', 'GPE'),\n",
      " ('MA', 'GPE'),\n",
      " ('USA', 'GPE'),\n",
      " ('1029.1', 'CARDINAL'),\n",
      " ('1033.2', 'CARDINAL'),\n",
      " ('BEH300 C18', 'ORG'),\n",
      " ('2.1', 'CARDINAL'),\n",
      " ('9 50 mm', 'TIME'),\n",
      " ('Elstree', 'GPE'),\n",
      " ('UK', 'GPE'),\n",
      " ('0.729', 'CARDINAL'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('41', 'CARDINAL'),\n",
      " ('10', 'CARDINAL'),\n",
      " ('Fig', 'PERSON'),\n",
      " ('1', 'CARDINAL'),\n",
      " ('Pharmacokinetics', 'ORG'),\n",
      " ('Safety and Tolerability of Oral Semaglutide', 'ORG'),\n",
      " ('15732.1.2', 'CARDINAL'),\n",
      " ('K 3EDTA', 'GPE'),\n",
      " ('at - 20', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'fivefold dilution of each sample',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '60.8 nmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': '60.8 nmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'A',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'A',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'stable isotope-labelled ana- logue of semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'stable isotope-labelled ana- logue of semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'standard',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'standard',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AB Sciex API QTrap/C2105500',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'AB Sciex API QTrap/C2105500',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'mass',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'mass',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'spectrometer',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'spectrometer',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Positive ions',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'Positive ions',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'multiple reac- tion-monitoring (MRM) mode',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'multiple reac- tion-monitoring (MRM) mode',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'mass transitions',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'mass transitions',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'm/ z 1029.1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'm/ z 1029.1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '136.0 Da',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': '136.0 Da',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'm',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'm',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '/z 1033.2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '/z 1033.2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'LC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'LC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Waters Acquity UPLC/C210system',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'Waters Acquity UPLC/C210system',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'LC column',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'LC column',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Acquity UPLC /C210 BEH300 C18, 2.1 9 50 mm',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'Acquity UPLC /C210 BEH300 C18, 2.1 9 50 mm',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'peak area ratios',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'peak area ratios',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'sem',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'sem',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'IS',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'IS',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'calibration curve fitting',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'calibration curve fitting',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'weighted linear regression (1/concentration2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'weighted linear regression (1/concentration2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglut',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'aglut',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '0.729 nmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '0.729 nmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'Oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'tablet',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'tablet',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '5 mg',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '5 mg',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'impaired renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'impaired renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '5 days 5 days',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '5 days 5 days',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Once-daily',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'Once-daily',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'PK sampling',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'PK sampling',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'syad 41-0syad 12 Normal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'syad 41-0syad 12 Normal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '-stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '-stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '10 mg',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '10 mg',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'Renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'Renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '.1.2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '.1.2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Venous blood',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'Venous blood',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'K 3EDTA tubes',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'K 3EDTA tubes',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '- 20 /C176C',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': '- 20 /C176C',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '60.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '60.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Sciex API QTrap',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'Sciex API QTrap',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Sciex',\n",
      "  'target_type': 'NORP'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'Sciex',\n",
      "  'source_type': 'NORP',\n",
      "  'target': 'Framingham',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': 'Framingham',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'MA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': 'MA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'USA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': 'USA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': '1029.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': '1029.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1033.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': '1033.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'BEH300 C18',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': 'BEH300 C18',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': '2.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '9 50 mm',\n",
      "  'target_type': 'TIME'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': '9 50 mm',\n",
      "  'source_type': 'TIME',\n",
      "  'target': 'Elstree',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': 'Elstree',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'UK',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': 'UK',\n",
      "  'source_type': 'GPE',\n",
      "  'target': '0.729',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': '0.729',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': '5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '41',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': '41',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '10',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '10',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Fig',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': 'Fig',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': '1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Pharmacokinetics',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': 'Pharmacokinetics',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Safety and Tolerability of Oral Semaglutide',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATS',\n",
      "  'source': 'Safety and Tolerability of Oral Semaglutide',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '15732.1.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Administered before',\n",
      "  'source': '15732.1.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'K 3EDTA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADD-ON TREATMENT',\n",
      "  'source': 'K 3EDTA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'at - 20',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 70 nodes and 69 relationships.\n",
      "graph_3.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('LC–MS/MS assay', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('in-line', 'DETAILED_DESCRIPTION'),\n",
      " ('solid-phase sample preparation', 'DETAILED_DESCRIPTION'),\n",
      " ('LC–MS/MS', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('bioanalysis of plasma samples', 'DETAILED_DESCRIPTION'),\n",
      " ('fivefold dilution of each sample', 'DETAILED_DESCRIPTION'),\n",
      " ('structural analogue of SNAC', 'DETAILED_DESCRIPTION'),\n",
      " ('AB SCIEX API 4000TM', 'DETAILED_DESCRIPTION'),\n",
      " ('Triple Quadrupole', 'DETAILED_DESCRIPTION'),\n",
      " ('Mass Spectrometer', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Negative ions', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('MRM mode', 'DETAILED_DESCRIPTION'),\n",
      " ('mass transitions', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('m/ z', 'LAB_VALUE'),\n",
      " ('278.1', 'LAB_VALUE'),\n",
      " ('118.0 Da', 'LAB_VALUE'),\n",
      " ('m', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('/', 'LAB_VALUE'),\n",
      " ('z', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('249.0', 'LAB_VALUE'),\n",
      " ('135.0 Da', 'LAB_VALUE'),\n",
      " ('Cohesive Turbulent Flow sys- tem', 'DETAILED_DESCRIPTION'),\n",
      " ('LC loading column', 'DETAILED_DESCRIPTION'),\n",
      " ('TurboFlow TM Cyclone-P, 50 9 0.5 mm', 'DETAILED_DESCRIPTION'),\n",
      " ('analytical column', 'DETAILED_DESCRIPTION'),\n",
      " ('Onyx TM Monolithic C18, 50 9 2.0 mm', 'DETAILED_DESCRIPTION'),\n",
      " ('Quan', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('tification', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('peak area ratios', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('SNAC versus IS', 'DETAILED_DESCRIPTION'),\n",
      " ('calibration', 'DETAILED_DESCRIPTION'),\n",
      " ('curve fitting', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('weighted linear regression (1/concentration 2', 'DETAILED_DESCRIPTION'),\n",
      " ('5.00 ng/mL', 'LAB_VALUE'),\n",
      " ('Urine', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('urine pre-dose', 'DETAILED_DESCRIPTION'),\n",
      " ('day 1', 'DATE'),\n",
      " ('days 10–11', 'DATE'),\n",
      " ('- ated urine collection', 'DETAILED_DESCRIPTION'),\n",
      " ('predefined intervals', 'DETAILED_DESCRIPTION'),\n",
      " ('glutide', 'DETAILED_DESCRIPTION'),\n",
      " ('SNAC', 'DETAILED_DESCRIPTION'),\n",
      " ('- 20 /C176C', 'LAB_VALUE'),\n",
      " ('Celerion Switzerland AG', 'ORG'),\n",
      " ('Fehraltorf', 'GPE'),\n",
      " ('Switzerland', 'GPE'),\n",
      " ('5.00–2000', 'CARDINAL'),\n",
      " ('2000', 'DATE'),\n",
      " ('4000TM', 'CARDINAL'),\n",
      " ('Spectrometer', 'PERSON'),\n",
      " ('Sciex', 'NORP'),\n",
      " ('Framingham', 'GPE'),\n",
      " ('MA', 'GPE'),\n",
      " ('USA', 'GPE'),\n",
      " ('118.0', 'CARDINAL'),\n",
      " ('50', 'CARDINAL'),\n",
      " ('Thermo Fisher Scientiﬁc', 'ORG'),\n",
      " ('Waltham', 'GPE'),\n",
      " ('Onyx TM Monolithic C18', 'ORG'),\n",
      " ('50 9 2.0 mm', 'TIME'),\n",
      " ('Phenomenex', 'PRODUCT'),\n",
      " ('1/concentration 2', 'MONEY'),\n",
      " ('5.00', 'CARDINAL'),\n",
      " ('day 1 and on days 10–11', 'DATE'),\n",
      " ('2.1.3', 'CARDINAL'),\n",
      " ('Semaglutide', 'WORK_OF_ART'),\n",
      " ('at - 20', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'LC–MS/MS assay',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'in-line',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'in-line',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'solid-phase sample preparation',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'solid-phase sample preparation',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'LC–MS/MS',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'LC–MS/MS',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'bioanalysis of plasma samples',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'bioanalysis of plasma samples',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'fivefold dilution of each sample',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'fivefold dilution of each sample',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'structural analogue of SNAC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'structural analogue of SNAC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AB SCIEX API 4000TM',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'AB SCIEX API 4000TM',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Triple Quadrupole',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'Triple Quadrupole',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Mass Spectrometer',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'Mass Spectrometer',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Negative ions',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'Negative ions',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'MRM mode',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'MRM mode',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'mass transitions',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'mass transitions',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'm/ z',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'm/ z',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '278.1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '278.1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '118.0 Da',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '118.0 Da',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'm',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'm',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '/',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '/',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'z',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'z',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '249.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '249.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '135.0 Da',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '135.0 Da',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Cohesive Turbulent Flow sys- tem',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'Cohesive Turbulent Flow sys- tem',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'LC loading column',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'LC loading column',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'TurboFlow TM Cyclone-P, 50 9 0.5 mm',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'TurboFlow TM Cyclone-P, 50 9 0.5 mm',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'analytical column',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'analytical column',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Onyx TM Monolithic C18, 50 9 2.0 mm',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Onyx TM Monolithic C18, 50 9 2.0 mm',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Quan',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Quan',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'tification',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'tification',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'peak area ratios',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'peak area ratios',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'SNAC versus IS',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'SNAC versus IS',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'calibration',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'calibration',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'curve fitting',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'curve fitting',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'weighted linear regression (1/concentration 2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'weighted linear regression (1/concentration 2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '5.00 ng/mL',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '5.00 ng/mL',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Urine',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'Urine',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'urine pre-dose',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'urine pre-dose',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'day 1',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'day 1',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'days 10–11',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'days 10–11',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '- ated urine collection',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '- ated urine collection',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'predefined intervals',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'predefined intervals',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'glutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'SNAC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'SNAC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '- 20 /C176C',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '- 20 /C176C',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Celerion Switzerland AG',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'Celerion Switzerland AG',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Fehraltorf',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'Fehraltorf',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Switzerland',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'Switzerland',\n",
      "  'source_type': 'GPE',\n",
      "  'target': '5.00–2000',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '5.00–2000',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2000',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': '2000',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '4000TM',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '4000TM',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Spectrometer',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': 'Spectrometer',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Sciex',\n",
      "  'target_type': 'NORP'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': 'Sciex',\n",
      "  'source_type': 'NORP',\n",
      "  'target': 'Framingham',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': 'Framingham',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'MA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': 'MA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'USA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': 'USA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': '118.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': '118.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '50',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': '50',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Thermo Fisher Scientiﬁc',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': 'Thermo Fisher Scientiﬁc',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Waltham',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': 'Waltham',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Onyx TM Monolithic C18',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': 'Onyx TM Monolithic C18',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '50 9 2.0 mm',\n",
      "  'target_type': 'TIME'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': '50 9 2.0 mm',\n",
      "  'source_type': 'TIME',\n",
      "  'target': 'Phenomenex',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': 'Phenomenex',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': '1/concentration 2',\n",
      "  'target_type': 'MONEY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': '1/concentration 2',\n",
      "  'source_type': 'MONEY',\n",
      "  'target': '5.00',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '5.00',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'day 1 and on days 10–11',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': 'day 1 and on days 10–11',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '2.1.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': '2.1.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Semaglutide',\n",
      "  'target_type': 'WORK_OF_ART'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': 'Semaglutide',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': 'at - 20',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 67 nodes and 66 relationships.\n",
      "graph_4.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('1', 'DETAILED_DESCRIPTION'),\n",
      " ('%', 'DOSAGE'),\n",
      " ('Triton TM X-100', 'MEDICATION'),\n",
      " ('Sigma-Aldrich, Saint Louis, MO, USA', 'DETAILED_DESCRIPTION'),\n",
      " ('urine', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('ratio of', 'DETAILED_DESCRIPTION'),\n",
      " ('1 part per 9 parts', 'DOSAGE'),\n",
      " ('LC–MS/MS', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('SNAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('SNAC metabolites', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglutide plasma concentra- tion–time', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('zero to 24 h after the tenth', 'DATE'),\n",
      " ('24,Day10', 'DATE'),\n",
      " ('normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('renal', 'DISEASE_DISORDER'),\n",
      " ('impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('1%', 'PERCENT'),\n",
      " ('Saint Louis', 'GPE'),\n",
      " ('MO', 'GPE'),\n",
      " ('USA', 'GPE'),\n",
      " ('9', 'CARDINAL'),\n",
      " ('Triton X-100', 'ORG'),\n",
      " ('1.111', 'CARDINAL'),\n",
      " ('2.2', 'CARDINAL'),\n",
      " ('zero', 'CARDINAL'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('tenth', 'ORDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': '1',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '%',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': '%',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'Triton TM X-100',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'Triton TM X-100',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'Sigma-Aldrich, Saint Louis, MO, USA',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Sigma-Aldrich, Saint Louis, MO, USA',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'urine',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'urine',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'ratio of',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'ratio of',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '1 part per 9 parts',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '1 part per 9 parts',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'LC–MS/MS',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'LC–MS/MS',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'SNAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'SNAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'SNAC metabolites',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'SNAC metabolites',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglutide plasma concentra- tion–time',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'semaglutide plasma concentra- tion–time',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'zero to 24 h after the tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'zero to 24 h after the tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24,Day10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '24,Day10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '1%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '1%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': 'Saint Louis',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'Saint Louis',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'MO',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'MO',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'USA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'USA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': '9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Triton X-100',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'Triton X-100',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1.111',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '1.111',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '2.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'zero',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'zero',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'ORDINAL'}]\n",
      "Graph created with 28 nodes and 27 relationships.\n",
      "graph_5.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('log(AUC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('24,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('normal renal function group', 'DETAILED_DESCRIPTION'),\n",
      " ('11', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment groups', 'DETAILED_DESCRIPTION'),\n",
      " (',Day10', 'LAB_VALUE'),\n",
      " ('normal renal function group and a specific renal impairment group',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('AUC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglutide plasma concentration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('0–24 h after', 'DATE'),\n",
      " ('tenth', 'DATE'),\n",
      " ('renal clearance', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('36 h after', 'DATE'),\n",
      " ('terminal half-life', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('tenth dose', 'DETAILED_DESCRIPTION'),\n",
      " ('one dose', 'DETAILED_DESCRIPTION'),\n",
      " ('0.60', 'CARDINAL'),\n",
      " ('Twenty-two', 'CARDINAL'),\n",
      " ('at least 80%', 'PERCENT'),\n",
      " ('two', 'CARDINAL'),\n",
      " ('90%', 'PERCENT'),\n",
      " ('CI', 'ORG'),\n",
      " ('0.66', 'CARDINAL'),\n",
      " ('^R', 'CARDINAL'),\n",
      " ('1.51', 'CARDINAL'),\n",
      " ('the AUC 24,Day10', 'PRODUCT'),\n",
      " ('Cmax', 'PERSON'),\n",
      " ('half', 'CARDINAL'),\n",
      " ('( t/C145,Day10', 'DATE'),\n",
      " ('at least one', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'log(AUC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '24,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': '24,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal renal function group',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'normal renal function group',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '11',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': '11',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment groups',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'renal impairment groups',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': ',Day10',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': ',Day10',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'normal renal function group and a specific renal impairment group',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'normal renal function group and a specific renal impairment group',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AUC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'AUC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglutide plasma concentration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'semaglutide plasma concentration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '0–24 h after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '0–24 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'renal clearance',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'renal clearance',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '36 h after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '36 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'terminal half-life',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'terminal half-life',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'tenth dose',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'tenth dose',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'one dose',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'one dose',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '0.60',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '0.60',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Twenty-two',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'Twenty-two',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'at least 80%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'at least 80%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': 'two',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'two',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '90%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '90%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': 'CI',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'CI',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '0.66',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '0.66',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '^R',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '^R',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.51',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '1.51',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'the AUC 24,Day10',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'the AUC 24,Day10',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'half',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'half',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '( t/C145,Day10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '( t/C145,Day10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'at least one',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 31 nodes and 30 relationships.\n",
      "graph_6.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('AUC24,Day10', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('linear trapezoidal method based on observed values', 'DETAILED_DESCRIPTION'),\n",
      " ('actual sampling times', 'DETAILED_DESCRIPTION'),\n",
      " ('Cmax', 'DIAGNOSTIC_PROCEDURE'),\n",
      " (',Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('tmax,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('pharmacokinetic', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('profiles', 'DETAILED_DESCRIPTION'),\n",
      " ('t/C145,Day 10', 'DETAILED_DESCRIPTION'),\n",
      " ('ln(', 'DETAILED_DESCRIPTION'),\n",
      " ('2', 'LAB_VALUE'),\n",
      " (')', 'DETAILED_DESCRIPTION'),\n",
      " ('/ kz', 'LAB_VALUE'),\n",
      " ('terminal', 'DETAILED_DESCRIPTION'),\n",
      " ('elimination rate constant', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('kz', 'LAB_VALUE'),\n",
      " ('log-linear regression on the terminal part of the pharmacokinetic profiles',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('Cmax,Day10', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('normal renal function group', 'DETAILED_DESCRIPTION'),\n",
      " ('each of the four groups of subjects with renal impairment',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('linear normal model', 'DETAILED_DESCRIPTION'),\n",
      " ('log-transformed endpoint', 'DETAILED_DESCRIPTION'),\n",
      " ('log (weight) and age', 'DETAILED_DESCRIPTION'),\n",
      " ('categorical fixed', 'DETAILED_DESCRIPTION'),\n",
      " ('four renal impairment groups', 'DETAILED_DESCRIPTION'),\n",
      " ('with normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('-transformed', 'DETAILED_DESCRIPTION'),\n",
      " ('normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('back-transformed to', 'DETAILED_DESCRIPTION'),\n",
      " ('original scale', 'DETAILED_DESCRIPTION'),\n",
      " ('linear', 'ORG'),\n",
      " ('log-linear', 'ORG'),\n",
      " ('four', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'AUC24,Day10',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'linear trapezoidal method based on observed values',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'linear trapezoidal method based on observed values',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'actual sampling times',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'actual sampling times',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': ',Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': ',Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'tmax,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'tmax,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'pharmacokinetic',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'pharmacokinetic',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'profiles',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'profiles',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 't/C145,Day 10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 't/C145,Day 10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ln(',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'ln(',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': ')',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': ')',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '/ kz',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': '/ kz',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'terminal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'terminal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'elimination rate constant',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'elimination rate constant',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'kz',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'kz',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'log-linear regression on the terminal part of the pharmacokinetic '\n",
      "            'profiles',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'log-linear regression on the terminal part of the pharmacokinetic '\n",
      "            'profiles',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Cmax,Day10',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'Cmax,Day10',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'normal renal function group',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'normal renal function group',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'each of the four groups of subjects with renal impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'each of the four groups of subjects with renal impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'linear normal model',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'linear normal model',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'log-transformed endpoint',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'log-transformed endpoint',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'log (weight) and age',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'log (weight) and age',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'categorical fixed',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'categorical fixed',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'four renal impairment groups',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'four renal impairment groups',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'with normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'with normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '-transformed',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '-transformed',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'back-transformed to',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'back-transformed to',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'original scale',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'original scale',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'linear',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'linear',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'log-linear',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'log-linear',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'four',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 34 nodes and 33 relationships.\n",
      "graph_7.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('aglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('semaglutide from 144 to 148 h during haemodialysis', 'DETAILED_DESCRIPTION'),\n",
      " ('day 16', 'DATE'),\n",
      " ('predicted AUC of semaglutide from 144 to 148 h', 'DETAILED_DESCRIPTION'),\n",
      " ('elimination rate', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglutide plasma concentrations between two haemodialysis sessions at 76, '\n",
      "  '96, 120 and 144 h',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('after', 'DETAILED_DESCRIPTION'),\n",
      " ('tenth', 'DETAILED_DESCRIPTION'),\n",
      " ('cokinetic endpoints', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('estimated', 'DETAILED_DESCRIPTION'),\n",
      " ('glomerular filtration rate', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('eGFR', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Modification', 'DISEASE_DISORDER'),\n",
      " ('of Diet in', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal Disease', 'DISEASE_DISORDER'),\n",
      " ('(MDRD) equation', 'DETAILED_DESCRIPTION'),\n",
      " ('NAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('24,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('Cmax,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('tmax,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('area under', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('SNAC plasma concentration– time curve', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('time zero to 4 h', 'DETAILED_DESCRIPTION'),\n",
      " ('haemodialysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('day 9', 'DATE'),\n",
      " ('haemo', 'DETAILED_DESCRIPTION'),\n",
      " ('dialysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('day 10', 'DATE'),\n",
      " ('linear normal model', 'DETAILED_DESCRIPTION'),\n",
      " ('log-transformed endpoint', 'DETAILED_DESCRIPTION'),\n",
      " ('90%', 'PERCENT'),\n",
      " ('144', 'CARDINAL'),\n",
      " ('148', 'CARDINAL'),\n",
      " ('dial /AUC144–148 h', 'ORG'),\n",
      " ('two', 'CARDINAL'),\n",
      " ('76', 'DATE'),\n",
      " ('96', 'DATE'),\n",
      " ('120', 'CARDINAL'),\n",
      " ('1574', 'CARDINAL'),\n",
      " ('C. Granhall et al', 'PERSON'),\n",
      " ('the Modiﬁcation of Diet in', 'ORG'),\n",
      " ('MDRD', 'ORG'),\n",
      " ('21', 'CARDINAL'),\n",
      " ('CLR', 'ORG'),\n",
      " ('zero', 'CARDINAL'),\n",
      " ('4', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'semaglutide from 144 to 148 h during haemodialysis',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'semaglutide from 144 to 148 h during haemodialysis',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'day 16',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'day 16',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'predicted AUC of semaglutide from 144 to 148 h',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'predicted AUC of semaglutide from 144 to 148 h',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'elimination rate',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'elimination rate',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglutide plasma concentrations between two haemodialysis '\n",
      "            'sessions at 76, 96, 120 and 144 h',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'semaglutide plasma concentrations between two haemodialysis '\n",
      "            'sessions at 76, 96, 120 and 144 h',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'after',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'after',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'cokinetic endpoints',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'cokinetic endpoints',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'estimated',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'estimated',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glomerular filtration rate',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'glomerular filtration rate',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'eGFR',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'eGFR',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Modification',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'Modification',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'of Diet in',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'of Diet in',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal Disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'Renal Disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '(MDRD) equation',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '(MDRD) equation',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'NAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'NAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '24,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '24,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Cmax,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Cmax,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'tmax,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'tmax,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'area under',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'area under',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'SNAC plasma concentration– time curve',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'SNAC plasma concentration– time curve',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'time zero to 4 h',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'time zero to 4 h',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'haemodialysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'haemodialysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'day 9',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'day 9',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'haemo',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'haemo',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'dialysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'dialysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'day 10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'day 10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'linear normal model',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'linear normal model',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'log-transformed endpoint',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'log-transformed endpoint',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '90%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '90%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '144',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '144',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '148',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '148',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'dial /AUC144–148 h',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'dial /AUC144–148 h',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'two',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'two',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '76',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '76',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '96',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '96',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '120',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '120',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1574',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '1574',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'C. Granhall et al',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'C. Granhall et al',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'the Modiﬁcation of Diet in',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'the Modiﬁcation of Diet in',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'MDRD',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'MDRD',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '21',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '21',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CLR',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'CLR',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'zero',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'zero',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 48 nodes and 47 relationships.\n",
      "graph_8.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('SAS/C210version 9.3 or 9.4', 'DETAILED_DESCRIPTION'),\n",
      " ('NC', 'DETAILED_DESCRIPTION'),\n",
      " ('hypoglycaemic', 'SIGN_SYMPTOM'),\n",
      " ('Diabetes Association', 'DETAILED_DESCRIPTION'),\n",
      " ('ADA', 'DETAILED_DESCRIPTION'),\n",
      " ('third- party assistance', 'DETAILED_DESCRIPTION'),\n",
      " ('plasma glucose', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('3.1 mmol/L', 'LAB_VALUE'),\n",
      " ('56 mg/dL', 'LAB_VALUE'),\n",
      " ('laboratory', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('physical examination', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('vital signs', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('electrocardiogram', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('24', 'LAB_VALUE'),\n",
      " ('normal', 'LAB_VALUE'),\n",
      " ('renal function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('12', 'LAB_VALUE'),\n",
      " ('mild', 'DETAILED_DESCRIPTION'),\n",
      " ('moderate', 'DETAILED_DESCRIPTION'),\n",
      " ('severe', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('based on the Cockcroft-Gault formula', 'DETAILED_DESCRIPTION'),\n",
      " ('11', 'LAB_VALUE'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('type 2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('two', 'LAB_VALUE'),\n",
      " ('type 1 diabetes', 'DISEASE_DISORDER'),\n",
      " ('eight', 'LAB_VALUE'),\n",
      " ('insulin analogues', 'MEDICATION'),\n",
      " ('antidiabetic drugs', 'MEDICATION'),\n",
      " ('mean concentration–time', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglu', 'MEDICATION'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('tide', 'MEDICATION'),\n",
      " ('tenth', 'DATE'),\n",
      " ('sem', 'MEDICATION'),\n",
      " ('glutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('10', 'DATE'),\n",
      " ('day 10', 'DATE'),\n",
      " ('SAS', 'ORG'),\n",
      " ('9.4', 'CARDINAL'),\n",
      " ('SAS Institute', 'ORG'),\n",
      " ('Cary', 'GPE'),\n",
      " ('USA', 'GPE'),\n",
      " ('the American Diabetes Association', 'ORG'),\n",
      " ('22', 'CARDINAL'),\n",
      " ('3.1', 'CARDINAL'),\n",
      " ('56', 'CARDINAL'),\n",
      " ('3', 'CARDINAL'),\n",
      " ('71', 'CARDINAL'),\n",
      " ('Twelve', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('1', 'CARDINAL'),\n",
      " ('six', 'CARDINAL'),\n",
      " ('Table 1', 'LAW'),\n",
      " ('3.2', 'CARDINAL'),\n",
      " ('Pharmacokinetics Geometric', 'PERSON'),\n",
      " ('Fig', 'PERSON')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'SAS/C210version 9.3 or 9.4',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'NC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'NC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'hypoglycaemic',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'hypoglycaemic',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'Diabetes Association',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Diabetes Association',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ADA',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'ADA',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'third- party assistance',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'third- party assistance',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'plasma glucose',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'plasma glucose',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '3.1 mmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': '3.1 mmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '56 mg/dL',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': '56 mg/dL',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'laboratory',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'laboratory',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'physical examination',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'physical examination',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'vital signs',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'vital signs',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'electrocardiogram',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'electrocardiogram',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '24',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '24',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '12',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '12',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'mild',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'mild',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'moderate',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'moderate',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'severe',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'severe',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'based on the Cockcroft-Gault formula',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'based on the Cockcroft-Gault formula',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '11',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '11',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'type 2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'type 2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'two',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'two',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'type 1 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'type 1 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'eight',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'eight',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'insulin analogues',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'insulin analogues',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'antidiabetic drugs',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'antidiabetic drugs',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'mean concentration–time',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'mean concentration–time',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglu',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'semaglu',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'tide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'tide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'sem',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'sem',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'glutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'day 10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'day 10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'SAS',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'SAS',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '9.4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '9.4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'SAS Institute',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'SAS Institute',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Cary',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'Cary',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'USA',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'USA',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'the American Diabetes Association',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'the American Diabetes Association',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '22',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': '22',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '3.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '56',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': '56',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': '3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '71',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '71',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Twelve',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': 'Twelve',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': '1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'six',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': 'six',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Table 1',\n",
      "  'target_type': 'LAW'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': 'Table 1',\n",
      "  'source_type': 'LAW',\n",
      "  'target': '3.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': '3.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Pharmacokinetics Geometric',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': 'Pharmacokinetics Geometric',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Fig',\n",
      "  'target_type': 'PERSON'}]\n",
      "Graph created with 60 nodes and 59 relationships.\n",
      "graph_9.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('normal renal', 'LAB_VALUE'),\n",
      " ('semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('mild', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('1', 'LAB_VALUE'),\n",
      " ('37', 'LAB_VALUE'),\n",
      " ('39', 'LAB_VALUE'),\n",
      " ('severe', 'DETAILED_DESCRIPTION'),\n",
      " ('10', 'DETAILED_DESCRIPTION'),\n",
      " ('0.61', 'LAB_VALUE'),\n",
      " ('61', 'LAB_VALUE'),\n",
      " ('Sema', 'MEDICATION'),\n",
      " ('glutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('moderate', 'DETAILED_DESCRIPTION'),\n",
      " ('normal', 'LAB_VALUE'),\n",
      " ('renal', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('Age', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('male', 'LAB_VALUE'),\n",
      " ('Weight', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('kg', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('84.9', 'LAB_VALUE'),\n",
      " ('83.4', 'LAB_VALUE'),\n",
      " ('87.2', 'LAB_VALUE'),\n",
      " ('85', 'LAB_VALUE'),\n",
      " ('5', 'LAB_VALUE'),\n",
      " ('75', 'LAB_VALUE'),\n",
      " ('0', 'LAB_VALUE'),\n",
      " ('Body mass index', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('kg/m 2', 'LAB_VALUE'),\n",
      " ('28', 'LAB_VALUE'),\n",
      " ('29', 'LAB_VALUE'),\n",
      " ('30', 'LAB_VALUE'),\n",
      " ('26', 'LAB_VALUE'),\n",
      " ('9', 'LAB_VALUE'),\n",
      " ('HbA1c', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('%', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Creatinine clearance', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('mL/min/1.73 m 2', 'LAB_VALUE'),\n",
      " ('diabetes', 'DISEASE_DISORDER'),\n",
      " ('ESRD end', 'DISEASE_DISORDER'),\n",
      " ('stage renal disease', 'DISEASE_DISORDER'),\n",
      " ('HbA', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('1c glycosylated haemoglobin', 'SIGN_SYMPTOM'),\n",
      " ('SD standard deviation', 'LAB_VALUE'),\n",
      " ('04 321 42216 5 10 15 20', 'DETAILED_DESCRIPTION'),\n",
      " ('Semaglutide plasma concentration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('nmol/L', 'LAB_VALUE'),\n",
      " ('SevereNormal', 'LAB_VALUE'),\n",
      " ('.729 nmol/L', 'LAB_VALUE'),\n",
      " ('–time', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('tenth', 'DATE'),\n",
      " ('1.37', 'CARDINAL'),\n",
      " ('90%', 'PERCENT'),\n",
      " ('CI 0.91–2.06] and Cmax', 'EVENT'),\n",
      " ('1.39', 'CARDINAL'),\n",
      " ('Cmax', 'PERSON'),\n",
      " ('0.42–0.87', 'CARDINAL'),\n",
      " ('Table 1 Baseline', 'PRODUCT'),\n",
      " ('Parameters Renal', 'ORG'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('11', 'CARDINAL'),\n",
      " ('Age (years', 'DATE'),\n",
      " ('52', 'CARDINAL'),\n",
      " ('8)', 'CARDINAL'),\n",
      " ('13', 'CARDINAL'),\n",
      " ('59', 'DATE'),\n",
      " ('57', 'DATE'),\n",
      " ('54', 'DATE'),\n",
      " ('15', 'CARDINAL'),\n",
      " ('62.5', 'CARDINAL'),\n",
      " ('41.7', 'CARDINAL'),\n",
      " ('75.0', 'CARDINAL'),\n",
      " ('63.6', 'CARDINAL'),\n",
      " ('12.9', 'CARDINAL'),\n",
      " ('19.5', 'CARDINAL'),\n",
      " ('15.8', 'CARDINAL'),\n",
      " ('12.2', 'CARDINAL'),\n",
      " ('15.3', 'CARDINAL'),\n",
      " ('28.4', 'CARDINAL'),\n",
      " ('3.9', 'CARDINAL'),\n",
      " ('29.0', 'CARDINAL'),\n",
      " ('5.5', 'CARDINAL'),\n",
      " ('30.1', 'CARDINAL'),\n",
      " ('5.2', 'CARDINAL'),\n",
      " ('28.5', 'CARDINAL'),\n",
      " ('26.9', 'CARDINAL'),\n",
      " ('5.3', 'CARDINAL'),\n",
      " ('0.3', 'CARDINAL'),\n",
      " ('5.9', 'CARDINAL'),\n",
      " ('0.7', 'CARDINAL'),\n",
      " ('6.0', 'CARDINAL'),\n",
      " ('0.8', 'CARDINAL'),\n",
      " ('6.1', 'CARDINAL'),\n",
      " ('0.6', 'CARDINAL'),\n",
      " ('6.2', 'CARDINAL'),\n",
      " ('1.3', 'CARDINAL'),\n",
      " ('107', 'CARDINAL'),\n",
      " ('90–132', 'CARDINAL'),\n",
      " ('71', 'DATE'),\n",
      " ('60–89', 'CARDINAL'),\n",
      " ('47', 'DATE'),\n",
      " ('34–56', 'CARDINAL'),\n",
      " ('18', 'CARDINAL'),\n",
      " ('15–27', 'CARDINAL'),\n",
      " ('0 2', 'CARDINAL'),\n",
      " ('16.7', 'CARDINAL'),\n",
      " ('3', 'CARDINAL'),\n",
      " ('25.0', 'CARDINAL'),\n",
      " ('4', 'CARDINAL'),\n",
      " ('36.4', 'CARDINAL'),\n",
      " ('Time', 'ORG'),\n",
      " ('0.729', 'CARDINAL'),\n",
      " ('2', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'normal renal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'mild',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'mild',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': '1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '37',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '37',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '39',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '39',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'severe',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'severe',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': '10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '0.61',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '0.61',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '61',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '61',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Sema',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'Sema',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'glutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'moderate',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'moderate',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'Renal function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Age',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'Age',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'male',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'male',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Weight',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Weight',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'kg',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'kg',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '84.9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '84.9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '83.4',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '83.4',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '87.2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '87.2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '85',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '85',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '5',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '5',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '75',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '75',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Body mass index',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Body mass index',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'kg/m 2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'kg/m 2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '28',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '28',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '29',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '29',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '30',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '30',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '26',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '26',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'HbA1c',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'HbA1c',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '%',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '%',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Creatinine clearance',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Creatinine clearance',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'mL/min/1.73 m 2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'mL/min/1.73 m 2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ESRD end',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'ESRD end',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'HbA',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'HbA',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '1c glycosylated haemoglobin',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '1c glycosylated haemoglobin',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'SD standard deviation',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'SD standard deviation',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '04 321 42216 5 10 15 20',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '04 321 42216 5 10 15 20',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Semaglutide plasma concentration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'Semaglutide plasma concentration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'nmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'nmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'SevereNormal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': 'SevereNormal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '.729 nmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': '.729 nmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '–time',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '–time',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '1.37',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': '1.37',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '90%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': '90%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': 'CI 0.91–2.06] and Cmax',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': 'CI 0.91–2.06] and Cmax',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '1.39',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': '1.39',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '0.42–0.87',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': '0.42–0.87',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Table 1 Baseline',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': 'Table 1 Baseline',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': 'Parameters Renal',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': 'Parameters Renal',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': '11',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Age (years',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': 'Age (years',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '52',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': '52',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '8)',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATS',\n",
      "  'source': '8)',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '13',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Administered before',\n",
      "  'source': '13',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '59',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADD-ON TREATMENT',\n",
      "  'source': '59',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '57',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MODIFIES',\n",
      "  'source': '57',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '54',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CO-OCCUR',\n",
      "  'source': '54',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ASSOCIATED_WITH',\n",
      "  'source': '15',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '62.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_LAB_VALUE',\n",
      "  'source': '62.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '41.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXPLORATORY_ENDPOINT',\n",
      "  'source': '41.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '75.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED TREATMENT',\n",
      "  'source': '75.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '63.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EVALUATES_TREATMENT_EFFECT',\n",
      "  'source': '63.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Used for monitoring',\n",
      "  'source': '12.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '19.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Reported',\n",
      "  'source': '19.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TRIAL_PERIOD',\n",
      "  'source': '15.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BETWEEN',\n",
      "  'source': '12.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIDE_EFFECT',\n",
      "  'source': '15.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '28.4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'REPRESENTED_BY',\n",
      "  'source': '28.4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Comparison',\n",
      "  'source': '3.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '29.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECT',\n",
      "  'source': '29.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_BODY_WEIGHT',\n",
      "  'source': '5.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '30.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED',\n",
      "  'source': '30.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATMENT_COMPARISON',\n",
      "  'source': '5.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '28.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received nonfinancial support from',\n",
      "  'source': '28.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '26.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_FIXED_EFFECT',\n",
      "  'source': '26.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON',\n",
      "  'source': '5.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DIAGNOSTIC_PROCEDURE',\n",
      "  'source': '0.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_HbA1c',\n",
      "  'source': '5.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DEFINED_AS',\n",
      "  'source': '0.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '6.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RESULTS_IN',\n",
      "  'source': '6.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PART_OF',\n",
      "  'source': '0.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '6.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Compared to',\n",
      "  'source': '6.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'collaborates with',\n",
      "  'source': '0.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '6.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DISCONTINUATION_RATE',\n",
      "  'source': '6.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BELONGS_TO',\n",
      "  'source': '1.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '107',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DECREASED_WITH',\n",
      "  'source': '107',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '90–132',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'USED_IN',\n",
      "  'source': '90–132',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '71',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OBSERVED_IN',\n",
      "  'source': '71',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '60–89',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECT ON',\n",
      "  'source': '60–89',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '47',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EMPLOYEE_OF',\n",
      "  'source': '47',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '34–56',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'LOWER_RATE_OF',\n",
      "  'source': '34–56',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '18',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MOST_FREQUENT_EVENT',\n",
      "  'source': '18',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15–27',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ENDS_AT',\n",
      "  'source': '15–27',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION',\n",
      "  'source': '0 2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '16.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ACHIEVED_TARGET_OF',\n",
      "  'source': '16.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Affects',\n",
      "  'source': '3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '25.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'USES_DATA_FROM',\n",
      "  'source': '25.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONFIRMED_BY',\n",
      "  'source': '4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '36.4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLEX REGIMEN COMPONENT',\n",
      "  'source': '36.4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Time',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SAFETY_ASSESSMENT',\n",
      "  'source': 'Time',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '0.729',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received grants from',\n",
      "  'source': '0.729',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 116 nodes and 115 relationships.\n",
      "graph_10.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Oral', 'DETAILED_DESCRIPTION'),\n",
      " ('glutide', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal Impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('categorised into renal function groups', 'DETAILED_DESCRIPTION'),\n",
      " ('eGFR', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('based on', 'DETAILED_DESCRIPTION'),\n",
      " ('MDRD', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('higher', 'LAB_VALUE'),\n",
      " ('apparent mean expo- sure', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('moderately', 'DETAILED_DESCRIPTION'),\n",
      " ('renal', 'DISEASE_DISORDER'),\n",
      " ('ly', 'DETAILED_DESCRIPTION'),\n",
      " ('impaired', 'DISEASE_DISORDER'),\n",
      " ('tmax,Day10', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('geometric mean for', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('t/C145,Day10', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('increase', 'LAB_VALUE'),\n",
      " ('152 h', 'LAB_VALUE'),\n",
      " ('normal', 'LAB_VALUE'),\n",
      " ('function', 'SIGN_SYMPTOM'),\n",
      " ('165 h', 'LAB_VALUE'),\n",
      " ('severe', 'DETAILED_DESCRIPTION'),\n",
      " ('ESRD', 'DETAILED_DESCRIPTION'),\n",
      " ('normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('urine', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('urine volume', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('CL R', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Pharmacokinetics, Safety and Tolerability of Oral Semaglutide', 'ORG'),\n",
      " ('1575function', 'CARDINAL'),\n",
      " ('1.0 to 1.5', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('152', 'CARDINAL'),\n",
      " ('165', 'CARDINAL'),\n",
      " ('one', 'CARDINAL'),\n",
      " ('CL', 'ORG')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'glutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal Impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'Renal Impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'categorised into renal function groups',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'categorised into renal function groups',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'eGFR',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'eGFR',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'based on',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'based on',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'MDRD',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'MDRD',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'higher',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'higher',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'apparent mean expo- sure',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'apparent mean expo- sure',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'moderately',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'moderately',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ly',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'ly',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'impaired',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'impaired',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'tmax,Day10',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'tmax,Day10',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'geometric mean for',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'geometric mean for',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 't/C145,Day10',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 't/C145,Day10',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'increase',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'increase',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '152 h',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '152 h',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'function',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'function',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': '165 h',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '165 h',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'severe',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'severe',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'urine',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'urine',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'urine volume',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'urine volume',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'CL R',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'CL R',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Pharmacokinetics, Safety and Tolerability of Oral Semaglutide',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Pharmacokinetics, Safety and Tolerability of Oral Semaglutide',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1575function',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '1575function',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.0 to 1.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '1.0 to 1.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '152',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '152',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '165',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '165',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'one',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'one',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CL',\n",
      "  'target_type': 'ORG'}]\n",
      "Graph created with 36 nodes and 35 relationships.\n",
      "graph_11.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Semaglutide plasma con- centrations', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('21 days after', 'DATE'),\n",
      " ('last', 'DATE'),\n",
      " ('Semaglutide exposure', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('plasma concentration–time curve', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('zero', 'DATE'),\n",
      " ('24 h after', 'DATE'),\n",
      " ('tenth', 'DATE'),\n",
      " ('function', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('semaglutide half-life', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('D', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('dialysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('aglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('impairment', 'DISEASE_DISORDER'),\n",
      " ('ten', 'DOSAGE'),\n",
      " ('once', 'DOSAGE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('daily', 'DOSAGE'),\n",
      " ('Oral', 'DETAILED_DESCRIPTION'),\n",
      " ('up to 21 days', 'DATE'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('half', 'CARDINAL'),\n",
      " ('152–165', 'CARDINAL'),\n",
      " ('one', 'CARDINAL'),\n",
      " ('ESRD', 'ORG'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('Key Points Renal', 'ORG')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Semaglutide plasma con- centrations',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '21 days after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': '21 days after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'last',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'last',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Semaglutide exposure',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Semaglutide exposure',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'plasma concentration–time curve',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'plasma concentration–time curve',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'zero',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'zero',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24 h after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '24 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'semaglutide half-life',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'semaglutide half-life',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'D',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'D',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'dialysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'dialysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ten',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'ten',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'once',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'once',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'daily',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'daily',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'Oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'up to 21 days',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'up to 21 days',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'half',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'half',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '152–165',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '152–165',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'one',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'one',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Key Points Renal',\n",
      "  'target_type': 'ORG'}]\n",
      "Graph created with 29 nodes and 28 relationships.\n",
      "graph_12.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('concentration–time profiles', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('S', 'DISEASE_DISORDER'),\n",
      " ('NAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('tenth', 'DATE'),\n",
      " ('AUC24', 'DIAGNOSTIC_PROCEDURE'),\n",
      " (',Day 10', 'DETAILED_DESCRIPTION'),\n",
      " ('increased', 'LAB_VALUE'),\n",
      " ('ESR', 'DETAILED_DESCRIPTION'),\n",
      " ('AUC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('24,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('group with normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('1.19', 'LAB_VALUE'),\n",
      " ('mild', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('1', 'LAB_VALUE'),\n",
      " ('30', 'LAB_VALUE'),\n",
      " ('49', 'LAB_VALUE'),\n",
      " ('32', 'LAB_VALUE'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('max,', 'DETAILED_DESCRIPTION'),\n",
      " ('Day10', 'DATE'),\n",
      " ('impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('0.94', 'LAB_VALUE'),\n",
      " ('0', 'LAB_VALUE'),\n",
      " ('06', 'LAB_VALUE'),\n",
      " ('79', 'LAB_VALUE'),\n",
      " ('time to reach the maximum concentration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('tmax', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('0.', 'LAB_VALUE'),\n",
      " ('58', 'DISTANCE'),\n",
      " ('83', 'DISTANCE'),\n",
      " ('clear', 'LAB_VALUE'),\n",
      " ('terminal phase', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('half-life', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('/C145', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Fig', 'PERSON'),\n",
      " ('4', 'CARDINAL'),\n",
      " ('Table 3', 'LAW'),\n",
      " ('The AUC24,Day 10', 'EVENT'),\n",
      " ('90%', 'PERCENT'),\n",
      " ('1.01–1.42', 'CARDINAL'),\n",
      " ('1.30', 'CARDINAL'),\n",
      " ('CI 1.08–1.57', 'DATE'),\n",
      " ('CI 1.26–1.75', 'DATE'),\n",
      " ('1.32', 'CARDINAL'),\n",
      " ('CI 1.13–1.55', 'WORK_OF_ART'),\n",
      " ('CI 0.63–1.41', 'WORK_OF_ART'),\n",
      " ('0.70', 'CARDINAL'),\n",
      " ('1.06', 'CARDINAL'),\n",
      " ('CI 0.64–1.75', 'EVENT'),\n",
      " ('0.79', 'CARDINAL'),\n",
      " ('CI 0.51–1.22', 'WORK_OF_ART'),\n",
      " ('0.58', 'CARDINAL'),\n",
      " ('0.83', 'CARDINAL'),\n",
      " ('half', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'concentration–time profiles',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'S',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'S',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'NAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'NAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'AUC24',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'AUC24',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': ',Day 10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': ',Day 10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'increased',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'increased',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'ESR',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'ESR',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AUC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'AUC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '24,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '24,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'group with normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'group with normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '1.19',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': '1.19',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'mild',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'mild',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '30',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '30',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '49',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '49',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '32',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '32',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'max,',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'max,',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Day10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Day10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '0.94',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '0.94',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '06',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '06',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '79',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '79',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'time to reach the maximum concentration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'time to reach the maximum concentration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'tmax',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'tmax',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '0.',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '0.',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '58',\n",
      "  'target_type': 'DISTANCE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '58',\n",
      "  'source_type': 'DISTANCE',\n",
      "  'target': '83',\n",
      "  'target_type': 'DISTANCE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '83',\n",
      "  'source_type': 'DISTANCE',\n",
      "  'target': 'clear',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'clear',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'terminal phase',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'terminal phase',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'half-life',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'half-life',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '/C145',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '/C145',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Fig',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'Fig',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Table 3',\n",
      "  'target_type': 'LAW'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Table 3',\n",
      "  'source_type': 'LAW',\n",
      "  'target': 'The AUC24,Day 10',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'The AUC24,Day 10',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '90%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '90%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '1.01–1.42',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '1.01–1.42',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.30',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '1.30',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CI 1.08–1.57',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'CI 1.08–1.57',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'CI 1.26–1.75',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'CI 1.26–1.75',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '1.32',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': '1.32',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CI 1.13–1.55',\n",
      "  'target_type': 'WORK_OF_ART'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'CI 1.13–1.55',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': 'CI 0.63–1.41',\n",
      "  'target_type': 'WORK_OF_ART'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'CI 0.63–1.41',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': '0.70',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '0.70',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.06',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': '1.06',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CI 0.64–1.75',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': 'CI 0.64–1.75',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '0.79',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '0.79',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CI 0.51–1.22',\n",
      "  'target_type': 'WORK_OF_ART'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': 'CI 0.51–1.22',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': '0.58',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': '0.58',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.83',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': '0.83',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'half',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 56 nodes and 55 relationships.\n",
      "graph_13.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('36 h after', 'DATE'),\n",
      " ('sem', 'MEDICATION'),\n",
      " ('glut', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal', 'DETAILED_DESCRIPTION'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('283.7 (53.3', 'LAB_VALUE'),\n",
      " ('378.2 (78.9', 'LAB_VALUE'),\n",
      " ('298.5 (107.3', 'LAB_VALUE'),\n",
      " ('163.5 (65.6', 'LAB_VALUE'),\n",
      " ('287.7 (128.7', 'LAB_VALUE'),\n",
      " ('14', 'LAB_VALUE'),\n",
      " ('9 (53.2', 'LAB_VALUE'),\n",
      " ('20', 'LAB_VALUE'),\n",
      " ('2 (75.9', 'LAB_VALUE'),\n",
      " ('16', 'LAB_VALUE'),\n",
      " ('6 (102.0', 'LAB_VALUE'),\n",
      " ('8', 'LAB_VALUE'),\n",
      " ('6 (62.9', 'LAB_VALUE'),\n",
      " ('15', 'LAB_VALUE'),\n",
      " ('7 (128.3', 'LAB_VALUE'),\n",
      " ('1', 'LAB_VALUE'),\n",
      " ('151', 'LAB_VALUE'),\n",
      " ('7', 'LAB_VALUE'),\n",
      " ('9', 'LAB_VALUE'),\n",
      " ('159', 'LAB_VALUE'),\n",
      " ('3 (12.0', 'LAB_VALUE'),\n",
      " ('162', 'LAB_VALUE'),\n",
      " ('11.2', 'LAB_VALUE'),\n",
      " ('164', 'LAB_VALUE'),\n",
      " ('8.9', 'LAB_VALUE'),\n",
      " ('152', 'LAB_VALUE'),\n",
      " ('24', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('under the plasma concentration–time curve', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('zero', 'DATE'),\n",
      " ('24 h after', 'DATE'),\n",
      " ('tenth', 'DATE'),\n",
      " ('con', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('centration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('0', 'DATE'),\n",
      " ('ESRD end', 'DISEASE_DISORDER'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('stage renal disease', 'DISEASE_DISORDER'),\n",
      " ('100 200 300 400 500 600 700', 'DETAILED_DESCRIPTION'),\n",
      " ('1.37', 'LAB_VALUE'),\n",
      " ('Normal Mild Moderate', 'LAB_VALUE'),\n",
      " ('Severe', 'DETAILED_DESCRIPTION'),\n",
      " ('5 10 15 20 25 30 35 40', 'DETAILED_DESCRIPTION'),\n",
      " ('1.13', 'LAB_VALUE'),\n",
      " ('02', 'LAB_VALUE'),\n",
      " ('39', 'LAB_VALUE'),\n",
      " ('61', 'LAB_VALUE'),\n",
      " ('06', 'LAB_VALUE'),\n",
      " ('10', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('max', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('semaglut', 'MEDICATION'),\n",
      " ('ide', 'DETAILED_DESCRIPTION'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('Parameters Renal', 'ORG'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('11', 'CARDINAL'),\n",
      " ('nmol/C1h/L', 'EVENT'),\n",
      " ('283.7', 'CARDINAL'),\n",
      " ('53.3', 'CARDINAL'),\n",
      " ('378.2', 'CARDINAL'),\n",
      " ('78.9', 'CARDINAL'),\n",
      " ('298.5', 'CARDINAL'),\n",
      " ('107.3', 'CARDINAL'),\n",
      " ('163.5', 'CARDINAL'),\n",
      " ('65.6', 'CARDINAL'),\n",
      " ('287.7', 'CARDINAL'),\n",
      " ('128.7', 'CARDINAL'),\n",
      " ('14.9', 'CARDINAL'),\n",
      " ('53.2', 'CARDINAL'),\n",
      " ('20.2', 'CARDINAL'),\n",
      " ('75.9', 'CARDINAL'),\n",
      " ('16.6', 'CARDINAL'),\n",
      " ('102.0', 'CARDINAL'),\n",
      " ('8.6', 'CARDINAL'),\n",
      " ('62.9', 'CARDINAL'),\n",
      " ('15.7', 'CARDINAL'),\n",
      " ('128.3', 'CARDINAL'),\n",
      " ('1.0', 'CARDINAL'),\n",
      " ('0.5', 'CARDINAL'),\n",
      " ('4.0', 'CARDINAL'),\n",
      " ('2.5', 'CARDINAL'),\n",
      " ('1.5', 'CARDINAL'),\n",
      " ('2.0', 'CARDINAL'),\n",
      " ('151.7', 'CARDINAL'),\n",
      " ('9.1', 'CARDINAL'),\n",
      " ('159.3', 'CARDINAL'),\n",
      " ('12.0', 'CARDINAL'),\n",
      " ('162.8', 'CARDINAL'),\n",
      " ('164.9', 'CARDINAL'),\n",
      " ('152.8', 'CARDINAL'),\n",
      " ('49.0', 'CARDINAL'),\n",
      " ('Cmax', 'PERSON'),\n",
      " ('centration 0–24 h', 'ORG'),\n",
      " ('half', 'CARDINAL'),\n",
      " ('0.91', 'CARDINAL'),\n",
      " ('2.06', 'CARDINAL'),\n",
      " ('0.69', 'CARDINAL'),\n",
      " ('1.84', 'CARDINAL'),\n",
      " ('1.02', 'CARDINAL'),\n",
      " ('0.59', 'CARDINAL'),\n",
      " ('1.79', 'CARDINAL'),\n",
      " ('1.39', 'CARDINAL'),\n",
      " ('0.93', 'CARDINAL'),\n",
      " ('1.20', 'CARDINAL'),\n",
      " ('0.75', 'CARDINAL'),\n",
      " ('1.93', 'CARDINAL'),\n",
      " ('0.42', 'CARDINAL'),\n",
      " ('0.87', 'CARDINAL'),\n",
      " ('0.61', 'CARDINAL'),\n",
      " ('0.88', 'CARDINAL'),\n",
      " ('1.06', 'CARDINAL'),\n",
      " ('3', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': '36 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'sem',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'sem',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glut',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'glut',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '283.7 (53.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '283.7 (53.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '378.2 (78.9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '378.2 (78.9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '298.5 (107.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': '298.5 (107.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '163.5 (65.6',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': '163.5 (65.6',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '287.7 (128.7',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '287.7 (128.7',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '14',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '14',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '9 (53.2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': '9 (53.2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '20',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': '20',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '2 (75.9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '2 (75.9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '16',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '16',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '6 (102.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '6 (102.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '8',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '8',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '6 (62.9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '6 (62.9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '15',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '15',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '7 (128.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '7 (128.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '151',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '151',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '7',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '7',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '159',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '159',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '3 (12.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '3 (12.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '162',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '162',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '11.2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '11.2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '164',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '164',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '8.9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '8.9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '152',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '152',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '24',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '24',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'under the plasma concentration–time curve',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'under the plasma concentration–time curve',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'zero',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'zero',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24 h after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '24 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'con',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'con',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'centration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'centration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '0',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '0',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'ESRD end',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'ESRD end',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '100 200 300 400 500 600 700',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '100 200 300 400 500 600 700',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '1.37',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '1.37',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Normal Mild Moderate',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'Normal Mild Moderate',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Severe',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'Severe',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '5 10 15 20 25 30 35 40',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '5 10 15 20 25 30 35 40',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '1.13',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': '1.13',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '02',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '02',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '39',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': '39',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '61',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': '61',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '06',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '06',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '10',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': '10',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'max',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': 'max',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'semaglut',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': 'semaglut',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'ide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': 'ide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Parameters Renal',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': 'Parameters Renal',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': '11',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'nmol/C1h/L',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': 'nmol/C1h/L',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '283.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': '283.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '53.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '53.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '378.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': '378.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '78.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': '78.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '298.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': '298.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '107.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATS',\n",
      "  'source': '107.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '163.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Administered before',\n",
      "  'source': '163.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '65.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADD-ON TREATMENT',\n",
      "  'source': '65.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '287.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MODIFIES',\n",
      "  'source': '287.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '128.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CO-OCCUR',\n",
      "  'source': '128.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '14.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ASSOCIATED_WITH',\n",
      "  'source': '14.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '53.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_LAB_VALUE',\n",
      "  'source': '53.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '20.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXPLORATORY_ENDPOINT',\n",
      "  'source': '20.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '75.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED TREATMENT',\n",
      "  'source': '75.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '16.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EVALUATES_TREATMENT_EFFECT',\n",
      "  'source': '16.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '102.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Used for monitoring',\n",
      "  'source': '102.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '8.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Reported',\n",
      "  'source': '8.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '62.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TRIAL_PERIOD',\n",
      "  'source': '62.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BETWEEN',\n",
      "  'source': '15.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '128.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIDE_EFFECT',\n",
      "  'source': '128.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'REPRESENTED_BY',\n",
      "  'source': '1.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Comparison',\n",
      "  'source': '0.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '4.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECT',\n",
      "  'source': '4.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_BODY_WEIGHT',\n",
      "  'source': '2.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED',\n",
      "  'source': '1.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATMENT_COMPARISON',\n",
      "  'source': '2.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '151.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received nonfinancial support from',\n",
      "  'source': '151.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '9.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_FIXED_EFFECT',\n",
      "  'source': '9.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '159.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON',\n",
      "  'source': '159.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DIAGNOSTIC_PROCEDURE',\n",
      "  'source': '12.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '162.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_HbA1c',\n",
      "  'source': '162.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '164.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DEFINED_AS',\n",
      "  'source': '164.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '152.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RESULTS_IN',\n",
      "  'source': '152.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '49.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PART_OF',\n",
      "  'source': '49.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Compared to',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'centration 0–24 h',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'collaborates with',\n",
      "  'source': 'centration 0–24 h',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'half',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DISCONTINUATION_RATE',\n",
      "  'source': 'half',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.91',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BELONGS_TO',\n",
      "  'source': '0.91',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2.06',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DECREASED_WITH',\n",
      "  'source': '2.06',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.69',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'USED_IN',\n",
      "  'source': '0.69',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.84',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OBSERVED_IN',\n",
      "  'source': '1.84',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.02',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECT ON',\n",
      "  'source': '1.02',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.59',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EMPLOYEE_OF',\n",
      "  'source': '0.59',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.79',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'LOWER_RATE_OF',\n",
      "  'source': '1.79',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.39',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MOST_FREQUENT_EVENT',\n",
      "  'source': '1.39',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.93',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ENDS_AT',\n",
      "  'source': '0.93',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.20',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION',\n",
      "  'source': '1.20',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.75',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ACHIEVED_TARGET_OF',\n",
      "  'source': '0.75',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.93',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Affects',\n",
      "  'source': '1.93',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.42',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'USES_DATA_FROM',\n",
      "  'source': '0.42',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.87',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONFIRMED_BY',\n",
      "  'source': '0.87',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.61',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLEX REGIMEN COMPONENT',\n",
      "  'source': '0.61',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.88',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SAFETY_ASSESSMENT',\n",
      "  'source': '0.88',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.06',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received grants from',\n",
      "  'source': '1.06',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 116 nodes and 115 relationships.\n",
      "graph_14.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('AUC24', 'DIAGNOSTIC_PROCEDURE'),\n",
      " (',Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('area under the', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('plasma concentration–time curve', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('0', 'DATE'),\n",
      " ('24 h after', 'DATE'),\n",
      " ('tenth', 'DATE'),\n",
      " ('CLR renal clearance', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Cmax', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('10 maximum plasma', 'DETAILED_DESCRIPTION'),\n",
      " ('concentration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('ESRD end-', 'DETAILED_DESCRIPTION'),\n",
      " ('stage renal', 'DISEASE_DISORDER'),\n",
      " ('disease 1576', 'DETAILED_DESCRIPTION'),\n",
      " ('D', 'DISEASE_DISORDER'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('144–148 h,dial /AUC144–148 h,pred', 'DETAILED_DESCRIPTION'),\n",
      " ('1', 'LAB_VALUE'),\n",
      " ('SNAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('non-dialysis day', 'DETAILED_DESCRIPTION'),\n",
      " ('AUC 4', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('S', 'LAB_VALUE'),\n",
      " ('NAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('day 9', 'DATE'),\n",
      " ('day 10', 'DATE'),\n",
      " ('0.95', 'LAB_VALUE'),\n",
      " ('25', 'LAB_VALUE'),\n",
      " ('95%', 'PERCENT'),\n",
      " ('90%', 'PERCENT'),\n",
      " ('0 to 24', 'CARDINAL'),\n",
      " ('CLR', 'ORG'),\n",
      " ('ESRD', 'ORG'),\n",
      " ('1576', 'DATE'),\n",
      " ('AUC 144–148', 'ORG'),\n",
      " ('dial /AUC144–148', 'ORG'),\n",
      " ('0.97', 'CARDINAL'),\n",
      " ('the AUC 4 of SNAC', 'PRODUCT'),\n",
      " ('CI 0.74–1.23', 'WORK_OF_ART'),\n",
      " ('3.3', 'CARDINAL'),\n",
      " ('Safety and Tolerability Across', 'ORG'),\n",
      " ('35.2%', 'PERCENT'),\n",
      " ('53', 'CARDINAL'),\n",
      " ('AEs', 'ORG'),\n",
      " ('4', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'AUC24',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': ',Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': ',Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'area under the',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'area under the',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'plasma concentration–time curve',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'plasma concentration–time curve',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '0',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': '0',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24 h after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '24 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'CLR renal clearance',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'CLR renal clearance',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '10 maximum plasma',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '10 maximum plasma',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'concentration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'concentration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'ESRD end-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'ESRD end-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'stage renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'stage renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'disease 1576',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'disease 1576',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'D',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'D',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '144–148 h,dial /AUC144–148 h,pred',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '144–148 h,dial /AUC144–148 h,pred',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'SNAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'SNAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'non-dialysis day',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'non-dialysis day',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AUC 4',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'AUC 4',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'S',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'S',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'NAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'NAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'day 9',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'day 9',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'day 10',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'day 10',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '0.95',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '0.95',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '25',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '25',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '95%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '95%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '90%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '90%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '0 to 24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '0 to 24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'CLR',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'CLR',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1576',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '1576',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'AUC 144–148',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'AUC 144–148',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'dial /AUC144–148',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'dial /AUC144–148',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '0.97',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '0.97',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'the AUC 4 of SNAC',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'the AUC 4 of SNAC',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': 'CI 0.74–1.23',\n",
      "  'target_type': 'WORK_OF_ART'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'CI 0.74–1.23',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': '3.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '3.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Safety and Tolerability Across',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'Safety and Tolerability Across',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '35.2%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '35.2%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '53',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '53',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'AEs',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'AEs',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 44 nodes and 43 relationships.\n",
      "graph_15.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('AEs', 'SIGN_SYMPTOM'),\n",
      " ('higher', 'LAB_VALUE'),\n",
      " ('renal', 'DISEASE_DISORDER'),\n",
      " ('impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('mild', 'LAB_VALUE'),\n",
      " ('48 events', 'LAB_VALUE'),\n",
      " ('four', 'LAB_VALUE'),\n",
      " ('five', 'LAB_VALUE'),\n",
      " ('moderate', 'DETAILED_DESCRIPTION'),\n",
      " ('AE', 'SIGN_SYMPTOM'),\n",
      " ('deaths', 'SIGN_SYMPTOM'),\n",
      " ('gastrointestinal', 'SIGN_SYMPTOM'),\n",
      " ('disorders', 'DISEASE_DISORDER'),\n",
      " ('abdominal', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('distension', 'SIGN_SYMPTOM'),\n",
      " ('vomiting', 'SIGN_SYMPTOM'),\n",
      " ('nausea', 'SIGN_SYMPTOM'),\n",
      " ('discomfort', 'SIGN_SYMPTOM'),\n",
      " ('Hypoglycaemia', 'SIGN_SYMPTOM'),\n",
      " ('plasma', 'DETAILED_DESCRIPTION'),\n",
      " ('glucose', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('n', 'DETAILED_DESCRIPTION'),\n",
      " ('3.1 mmol/L', 'LAB_VALUE'),\n",
      " ('56 mg/dL', 'LAB_VALUE'),\n",
      " ('two', 'LAB_VALUE'),\n",
      " ('dia- betes', 'DISEASE_DISORDER'),\n",
      " ('moderate renal impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('sulphonylureas', 'MEDICATION'),\n",
      " ('ESRD', 'DETAILED_DESCRIPTION'),\n",
      " ('insulin', 'MEDICATION'),\n",
      " ('symptomatic', 'DETAILED_DESCRIPTION'),\n",
      " ('hypo- glycaemia', 'SIGN_SYMPTOM'),\n",
      " ('three', 'LAB_VALUE'),\n",
      " ('moderate renal', 'DETAILED_DESCRIPTION'),\n",
      " ('severe', 'DETAILED_DESCRIPTION'),\n",
      " ('hypoglycaemic episodes', 'SIGN_SYMPTOM'),\n",
      " ('increase', 'LAB_VALUE'),\n",
      " ('mean pulse rate', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('end of', 'DATE'),\n",
      " ('25.0–58.3%', 'PERCENT'),\n",
      " ('20.8%', 'PERCENT'),\n",
      " ('48', 'CARDINAL'),\n",
      " ('23', 'CARDINAL'),\n",
      " ('3.1', 'CARDINAL'),\n",
      " ('dL', 'PERSON'),\n",
      " ('one', 'CARDINAL'),\n",
      " ('4', 'CARDINAL'),\n",
      " ('ADA', 'ORG'),\n",
      " ('22', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'AEs',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'higher',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'higher',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'mild',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'mild',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '48 events',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '48 events',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'four',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'four',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'five',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'five',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'moderate',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'moderate',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AE',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'AE',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'deaths',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'deaths',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'gastrointestinal',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'gastrointestinal',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'disorders',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'disorders',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'abdominal',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'abdominal',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'distension',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'distension',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'vomiting',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'vomiting',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'nausea',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'nausea',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'discomfort',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'discomfort',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'Hypoglycaemia',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'Hypoglycaemia',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'plasma',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'plasma',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glucose',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'glucose',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'n',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'n',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '3.1 mmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '3.1 mmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '56 mg/dL',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '56 mg/dL',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'two',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'two',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'dia- betes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'dia- betes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'moderate renal impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'moderate renal impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'sulphonylureas',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'sulphonylureas',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'insulin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'insulin',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'symptomatic',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'symptomatic',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'hypo- glycaemia',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'hypo- glycaemia',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'three',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'three',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'moderate renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'moderate renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'severe',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'severe',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'hypoglycaemic episodes',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'hypoglycaemic episodes',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'increase',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'increase',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'mean pulse rate',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'mean pulse rate',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'end of',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'end of',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '25.0–58.3%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '25.0–58.3%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '20.8%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '20.8%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '48',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '48',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '23',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '23',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '3.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'dL',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'dL',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'one',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'one',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': '4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'ADA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'ADA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '22',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 50 nodes and 49 relationships.\n",
      "graph_16.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('changes', 'LAB_VALUE'),\n",
      " ('systolic', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('diastolic blood pressure', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('physical examination', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('electrocardiogram', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('minor increases', 'LAB_VALUE'),\n",
      " ('mean', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('lipase values', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('renal', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('function', 'DETAILED_DESCRIPTION'),\n",
      " ('increase', 'LAB_VALUE'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('time', 'DETAILED_DESCRIPTION'),\n",
      " ('zero', 'DATE'),\n",
      " ('to', 'DETAILED_DESCRIPTION'),\n",
      " ('24 h', 'DATE'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('normal', 'LAB_VALUE'),\n",
      " ('renal function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('10 consecutive days', 'DURATION'),\n",
      " ('once', 'DOSAGE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('daily', 'DOSAGE'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('0 250 750 04 3216 57 8 1 0 1 2 1 8 2', 'DETAILED_DESCRIPTION'),\n",
      " ('500 1000 1250', 'DETAILED_DESCRIPTION'),\n",
      " ('NAC', 'DETAILED_DESCRIPTION'),\n",
      " ('/mL', 'LAB_VALUE'),\n",
      " ('Severe', 'LAB_VALUE'),\n",
      " ('Mild Moderate ESRD', 'DETAILED_DESCRIPTION'),\n",
      " ('–time', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('S', 'MEDICATION'),\n",
      " ('tenth', 'DATE'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('23–27', 'CARDINAL'),\n",
      " ('04', 'DATE'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('500', 'CARDINAL'),\n",
      " ('4', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'changes',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'systolic',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'systolic',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'diastolic blood pressure',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'diastolic blood pressure',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'physical examination',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'physical examination',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'electrocardiogram',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'electrocardiogram',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'minor increases',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'minor increases',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'mean',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'mean',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'lipase values',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'lipase values',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'increase',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'increase',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'time',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'time',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'zero',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'zero',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'to',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'to',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '24 h',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '24 h',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '10 consecutive days',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '10 consecutive days',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'once',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'once',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'daily',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'daily',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '0 250 750 04 3216 57 8 1 0 1 2 1 8 2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '0 250 750 04 3216 57 8 1 0 1 2 1 8 2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '500 1000 1250',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '500 1000 1250',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'NAC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'NAC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '/mL',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '/mL',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Severe',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Severe',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Mild Moderate ESRD',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'Mild Moderate ESRD',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '–time',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '–time',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'S',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'S',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '23–27',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '23–27',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '04',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '04',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '500',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '500',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 41 nodes and 40 relationships.\n",
      "graph_17.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('ESR', 'DETAILED_DESCRIPTION'),\n",
      " ('D end', 'DISEASE_DISORDER'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('stage renal disease', 'DISEASE_DISORDER'),\n",
      " (',', 'DETAILED_DESCRIPTION'),\n",
      " ('SNAC sodium N-(8-[2-hydroxybenzoyl] amino) caprylate',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('Pharmacokinetic', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('tenth', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal', 'DETAILED_DESCRIPTION'),\n",
      " ('function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('D', 'DISEASE_DISORDER'),\n",
      " ('AUC24,Day10', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('mol/C1h/L', 'LAB_VALUE'),\n",
      " ('1028.8', 'LAB_VALUE'),\n",
      " ('2', 'LAB_VALUE'),\n",
      " ('1311.6', 'LAB_VALUE'),\n",
      " ('31', 'LAB_VALUE'),\n",
      " ('5', 'LAB_VALUE'),\n",
      " ('1335.9', 'LAB_VALUE'),\n",
      " ('34', 'LAB_VALUE'),\n",
      " ('6', 'LAB_VALUE'),\n",
      " ('1522.8', 'LAB_VALUE'),\n",
      " ('1471.4', 'LAB_VALUE'),\n",
      " ('27.0', 'LAB_VALUE'),\n",
      " ('Cmax,', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('971.4 (89.4', 'LAB_VALUE'),\n",
      " ('1086.5 (99.0', 'LAB_VALUE'),\n",
      " ('734.7 (70.4', 'LAB_VALUE'),\n",
      " ('1074.4', 'LAB_VALUE'),\n",
      " ('95.0', 'LAB_VALUE'),\n",
      " ('936.3', 'LAB_VALUE'),\n",
      " ('88', 'LAB_VALUE'),\n",
      " ('t', 'DETAILED_DESCRIPTION'),\n",
      " ('0.75', 'LAB_VALUE'),\n",
      " ('0', 'LAB_VALUE'),\n",
      " ('58', 'LAB_VALUE'),\n",
      " ('67', 'LAB_VALUE'),\n",
      " ('83', 'LAB_VALUE'),\n",
      " ('CLR', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('L/h', 'LAB_VALUE'),\n",
      " ('0.06 (104.33', 'LAB_VALUE'),\n",
      " ('08 (87.88', 'LAB_VALUE'),\n",
      " ('09 (92.63', 'LAB_VALUE'),\n",
      " ('04', 'LAB_VALUE'),\n",
      " ('98.22', 'LAB_VALUE'),\n",
      " ('tmax', 'DETAILED_DESCRIPTION'),\n",
      " ('AUC24,', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('10', 'LAB_VALUE'),\n",
      " ('area under the plasma concentration–time curve', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('zero', 'DATE'),\n",
      " ('24 h after', 'DATE'),\n",
      " ('CLR renal clearance', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('concentration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('ESRD end-stage renal disease', 'DISEASE_DISORDER'),\n",
      " ('Oral Semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal Impairment 1577semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('subcutaneous injection', 'DETAILED_DESCRIPTION'),\n",
      " ('ESRD', 'ORG'),\n",
      " ('Table 3 Pharmacokinetic', 'PRODUCT'),\n",
      " ('Parameters Renal', 'ORG'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('11', 'CARDINAL'),\n",
      " ('nmol/C1h/L', 'EVENT'),\n",
      " ('29.2', 'CARDINAL'),\n",
      " ('31.5', 'CARDINAL'),\n",
      " ('34.6', 'CARDINAL'),\n",
      " ('31.8', 'CARDINAL'),\n",
      " ('971.4', 'CARDINAL'),\n",
      " ('89.4', 'CARDINAL'),\n",
      " ('1086.5', 'CARDINAL'),\n",
      " ('99.0', 'CARDINAL'),\n",
      " ('734.7', 'CARDINAL'),\n",
      " ('70.4', 'CARDINAL'),\n",
      " ('88.5', 'CARDINAL'),\n",
      " ('0.33', 'CARDINAL'),\n",
      " ('3.00', 'CARDINAL'),\n",
      " ('0.58', 'CARDINAL'),\n",
      " ('2.50', 'CARDINAL'),\n",
      " ('6.00', 'CARDINAL'),\n",
      " ('0.17', 'CARDINAL'),\n",
      " ('1.00', 'CARDINAL'),\n",
      " ('0.83', 'CARDINAL'),\n",
      " ('5.00', 'CARDINAL'),\n",
      " ('0.06', 'CARDINAL'),\n",
      " ('104.33', 'CARDINAL'),\n",
      " ('0.08', 'CARDINAL'),\n",
      " ('87.88', 'CARDINAL'),\n",
      " ('0.09', 'CARDINAL'),\n",
      " ('92.63', 'CARDINAL'),\n",
      " ('0.04', 'CARDINAL'),\n",
      " ('0.01', 'CARDINAL'),\n",
      " ('508.51', 'CARDINAL'),\n",
      " ('Cmax', 'PERSON'),\n",
      " ('Pharmacokinetics, Safety and Tolerability of Oral Semaglutide', 'ORG'),\n",
      " ('56', 'CARDINAL'),\n",
      " ('15', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'ESR',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'D end',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'D end',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': ',',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': ',',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'SNAC sodium N-(8-[2-hydroxybenzoyl] amino) caprylate',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'SNAC sodium N-(8-[2-hydroxybenzoyl] amino) caprylate',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Pharmacokinetic',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'Pharmacokinetic',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'tenth',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'tenth',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'Renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'D',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'D',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'AUC24,Day10',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'AUC24,Day10',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'mol/C1h/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'mol/C1h/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1028.8',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '1028.8',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1311.6',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '1311.6',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '31',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '31',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '5',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '5',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1335.9',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '1335.9',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '34',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '34',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '6',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '6',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1522.8',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '1522.8',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1471.4',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '1471.4',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '27.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '27.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Cmax,',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Cmax,',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '971.4 (89.4',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '971.4 (89.4',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1086.5 (99.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '1086.5 (99.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '734.7 (70.4',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '734.7 (70.4',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1074.4',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '1074.4',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '95.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '95.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '936.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '936.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '88',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '88',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 't',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 't',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '0.75',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '0.75',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '58',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '58',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '67',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '67',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '83',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '83',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'CLR',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'CLR',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'L/h',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'L/h',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '0.06 (104.33',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '0.06 (104.33',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '08 (87.88',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '08 (87.88',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '09 (92.63',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '09 (92.63',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '04',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': '04',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '98.22',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '98.22',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'tmax',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'tmax',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'AUC24,',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'AUC24,',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '10',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': '10',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'area under the plasma concentration–time curve',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': 'area under the plasma concentration–time curve',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'zero',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': 'zero',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '24 h after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': '24 h after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'CLR renal clearance',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': 'CLR renal clearance',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'concentration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': 'concentration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'ESRD end-stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': 'ESRD end-stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Oral Semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': 'Oral Semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal Impairment 1577semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': 'Renal Impairment 1577semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'subcutaneous injection',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': 'subcutaneous injection',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Table 3 Pharmacokinetic',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': 'Table 3 Pharmacokinetic',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': 'Parameters Renal',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': 'Parameters Renal',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': '11',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'nmol/C1h/L',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': 'nmol/C1h/L',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '29.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATS',\n",
      "  'source': '29.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '31.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Administered before',\n",
      "  'source': '31.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '34.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADD-ON TREATMENT',\n",
      "  'source': '34.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '31.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MODIFIES',\n",
      "  'source': '31.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '971.4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CO-OCCUR',\n",
      "  'source': '971.4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '89.4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ASSOCIATED_WITH',\n",
      "  'source': '89.4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1086.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_LAB_VALUE',\n",
      "  'source': '1086.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '99.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXPLORATORY_ENDPOINT',\n",
      "  'source': '99.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '734.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED TREATMENT',\n",
      "  'source': '734.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '70.4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EVALUATES_TREATMENT_EFFECT',\n",
      "  'source': '70.4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '88.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Used for monitoring',\n",
      "  'source': '88.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.33',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Reported',\n",
      "  'source': '0.33',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3.00',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TRIAL_PERIOD',\n",
      "  'source': '3.00',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.58',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BETWEEN',\n",
      "  'source': '0.58',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2.50',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIDE_EFFECT',\n",
      "  'source': '2.50',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '6.00',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'REPRESENTED_BY',\n",
      "  'source': '6.00',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.17',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Comparison',\n",
      "  'source': '0.17',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1.00',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECT',\n",
      "  'source': '1.00',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.83',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_BODY_WEIGHT',\n",
      "  'source': '0.83',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5.00',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED',\n",
      "  'source': '5.00',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.06',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATMENT_COMPARISON',\n",
      "  'source': '0.06',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '104.33',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received nonfinancial support from',\n",
      "  'source': '104.33',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.08',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_FIXED_EFFECT',\n",
      "  'source': '0.08',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '87.88',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON',\n",
      "  'source': '87.88',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.09',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DIAGNOSTIC_PROCEDURE',\n",
      "  'source': '0.09',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '92.63',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_HbA1c',\n",
      "  'source': '92.63',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.04',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DEFINED_AS',\n",
      "  'source': '0.04',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0.01',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RESULTS_IN',\n",
      "  'source': '0.01',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '508.51',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PART_OF',\n",
      "  'source': '508.51',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Compared to',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Pharmacokinetics, Safety and Tolerability of Oral Semaglutide',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'collaborates with',\n",
      "  'source': 'Pharmacokinetics, Safety and Tolerability of Oral Semaglutide',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '56',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DISCONTINUATION_RATE',\n",
      "  'source': '56',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 99 nodes and 98 relationships.\n",
      "graph_18.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('semaglutide', 'MEDICATION'),\n",
      " ('renal', 'DISEASE_DISORDER'),\n",
      " ('tmax for', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('function', 'DETAILED_DESCRIPTION'),\n",
      " ('t/C145', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('increase', 'LAB_VALUE'),\n",
      " ('renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('sem', 'MEDICATION'),\n",
      " ('a', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('glut', 'MEDICATION'),\n",
      " ('ide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('gastric', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('urine', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('D', 'DETAILED_DESCRIPTION'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('3.1% of', 'LAB_VALUE'),\n",
      " ('less', 'LAB_VALUE'),\n",
      " ('1%', 'LAB_VALUE'),\n",
      " ('mild', 'DETAILED_DESCRIPTION'),\n",
      " ('severe', 'DISTANCE'),\n",
      " ('haemodialysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('ESR', 'DISEASE_DISORDER'),\n",
      " ('GLP-1 analogues', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('liraglutide', 'MEDICATION'),\n",
      " ('ESRD', 'ORG'),\n",
      " ('one', 'CARDINAL'),\n",
      " ('3.1%', 'PERCENT'),\n",
      " ('less than 1%', 'PERCENT'),\n",
      " ('28', 'CARDINAL'),\n",
      " ('GLP-1', 'LOC'),\n",
      " ('15', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('29', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'tmax for',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'tmax for',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 't/C145',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 't/C145',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'increase',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'increase',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'sem',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'sem',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'a',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'a',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'glut',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'glut',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'ide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'ide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'gastric',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'gastric',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'urine',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'urine',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'D',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'D',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '3.1% of',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '3.1% of',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'less',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'less',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '1%',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '1%',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'mild',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'mild',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'severe',\n",
      "  'target_type': 'DISTANCE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'severe',\n",
      "  'source_type': 'DISTANCE',\n",
      "  'target': 'haemodialysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'haemodialysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'ESR',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'ESR',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'GLP-1 analogues',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'GLP-1 analogues',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'liraglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'liraglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'one',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'one',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3.1%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '3.1%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': 'less than 1%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'less than 1%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '28',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '28',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'LOC'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'LOC',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '15',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '29',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 34 nodes and 33 relationships.\n",
      "graph_19.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('har- maco', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('AUC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('24,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('increased', 'LAB_VALUE'),\n",
      " ('with increasing impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('ESRD', 'DETAILED_DESCRIPTION'),\n",
      " ('C', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('max,Day10', 'DETAILED_DESCRIPTION'),\n",
      " ('no', 'LAB_VALUE'),\n",
      " ('renal function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('decrease', 'LAB_VALUE'),\n",
      " ('CL R', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('accumula', 'LAB_VALUE'),\n",
      " ('tion', 'SIGN_SYMPTOM'),\n",
      " ('AUC 4', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('for SNAC', 'DETAILED_DESCRIPTION'),\n",
      " ('haemodialysis', 'DETAILED_DESCRIPTION'),\n",
      " ('not during haemodialysis', 'DETAILED_DESCRIPTION'),\n",
      " ('GLP-1 receptor agonist', 'MEDICATION'),\n",
      " ('therapy', 'DETAILED_DESCRIPTION'),\n",
      " ('renal', 'DISEASE_DISORDER'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('well', 'LAB_VALUE'),\n",
      " ('Cmax', 'PERSON'),\n",
      " ('CL', 'ORG'),\n",
      " ('the AUC 4', 'PRODUCT'),\n",
      " ('1', 'CARDINAL'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('15', 'CARDINAL'),\n",
      " ('23', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'har- maco',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'har- maco',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'AUC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'AUC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '24,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': '24,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'increased',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'increased',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'with increasing impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'with increasing impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'C',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'C',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'max,Day10',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'max,Day10',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'no',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'no',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'decrease',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'decrease',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'CL R',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'CL R',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'accumula',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'accumula',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'tion',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'tion',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'AUC 4',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'AUC 4',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'for SNAC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'for SNAC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'haemodialysis',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'haemodialysis',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'not during haemodialysis',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'not during haemodialysis',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'GLP-1 receptor agonist',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'GLP-1 receptor agonist',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'therapy',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'therapy',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'well',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'well',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Cmax',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Cmax',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'CL',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'CL',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'the AUC 4',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'the AUC 4',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': '1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '15',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '23',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 32 nodes and 31 relationships.\n",
      "graph_20.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('hypoglyc', 'SIGN_SYMPTOM'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('5 (20.8', 'LAB_VALUE'),\n",
      " ('5 7 (58.3', 'LAB_VALUE'),\n",
      " ('19 7 (58.3', 'LAB_VALUE'),\n",
      " ('16 3 (25.0', 'LAB_VALUE'),\n",
      " ('7 3 (27.3', 'LAB_VALUE'),\n",
      " ('6 25 (35.2', 'LAB_VALUE'),\n",
      " ('Abdominal', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('distension', 'SIGN_SYMPTOM'),\n",
      " ('1', 'LAB_VALUE'),\n",
      " ('Vomiting', 'SIGN_SYMPTOM'),\n",
      " ('Headache', 'SIGN_SYMPTOM'),\n",
      " ('Nausea', 'SIGN_SYMPTOM'),\n",
      " ('discomfort', 'SIGN_SYMPTOM'),\n",
      " ('Hypoglycaemia', 'SIGN_SYMPTOM'),\n",
      " ('ESRD end-stage renal disease', 'DISEASE_DISORDER'),\n",
      " ('American Diabetes Association (ADA', 'DETAILED_DESCRIPTION'),\n",
      " ('carbohydrates', 'MEDICATION'),\n",
      " ('glucagon', 'MEDICATION'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('30', 'CARDINAL'),\n",
      " ('31', 'CARDINAL'),\n",
      " ('32', 'CARDINAL'),\n",
      " ('Table 4', 'ORG'),\n",
      " ('N (%', 'PERCENT'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('11', 'CARDINAL'),\n",
      " ('71', 'CARDINAL'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('20.8', 'CARDINAL'),\n",
      " ('5 7', 'CARDINAL'),\n",
      " ('58.3', 'CARDINAL'),\n",
      " ('19 7', 'CARDINAL'),\n",
      " ('16 3', 'CARDINAL'),\n",
      " ('25.0', 'CARDINAL'),\n",
      " ('7 3', 'CARDINAL'),\n",
      " ('27.3', 'CARDINAL'),\n",
      " ('6 25', 'CARDINAL'),\n",
      " ('35.2', 'CARDINAL'),\n",
      " ('53', 'CARDINAL'),\n",
      " ('3%', 'PERCENT'),\n",
      " ('4.2', 'CARDINAL'),\n",
      " ('1 2', 'CARDINAL'),\n",
      " ('16.7', 'CARDINAL'),\n",
      " ('2 2', 'CARDINAL'),\n",
      " ('7 1', 'CARDINAL'),\n",
      " ('8.3', 'CARDINAL'),\n",
      " ('1 0', 'CARDINAL'),\n",
      " ('0 6', 'CARDINAL'),\n",
      " ('8.5', 'CARDINAL'),\n",
      " ('0 1', 'CARDINAL'),\n",
      " ('1 1', 'CARDINAL'),\n",
      " ('3 2', 'CARDINAL'),\n",
      " ('18.2', 'CARDINAL'),\n",
      " ('5 6', 'CARDINAL'),\n",
      " ('10', 'CARDINAL'),\n",
      " ('Headache 2', 'EVENT'),\n",
      " ('6 0', 'CARDINAL'),\n",
      " ('0 5', 'CARDINAL'),\n",
      " ('7.0', 'CARDINAL'),\n",
      " ('9', 'CARDINAL'),\n",
      " ('0 2', 'CARDINAL'),\n",
      " ('2 1', 'CARDINAL'),\n",
      " ('0 4', 'CARDINAL'),\n",
      " ('5.6', 'CARDINAL'),\n",
      " ('4', 'CARDINAL'),\n",
      " ('0 3', 'CARDINAL'),\n",
      " ('3 0', 'CARDINAL'),\n",
      " ('0 0', 'CARDINAL'),\n",
      " ('3', 'CARDINAL'),\n",
      " ('5 2', 'CARDINAL'),\n",
      " ('2 0', 'CARDINAL'),\n",
      " ('7', 'CARDINAL'),\n",
      " ('9.1', 'CARDINAL'),\n",
      " ('2.8', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('AE', 'ORG'),\n",
      " ('AEs', 'ORG'),\n",
      " ('American Diabetes Association', 'ORG'),\n",
      " ('ADA', 'ORG'),\n",
      " ('22', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'hypoglyc',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '5 (20.8',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': '5 (20.8',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '5 7 (58.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': '5 7 (58.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '19 7 (58.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': '19 7 (58.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '16 3 (25.0',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '16 3 (25.0',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '7 3 (27.3',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': '7 3 (27.3',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '6 25 (35.2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': '6 25 (35.2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Abdominal',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'Abdominal',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'distension',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'distension',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': '1',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Vomiting',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'Vomiting',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'Headache',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'Headache',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'Nausea',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'Nausea',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'discomfort',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'discomfort',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'Hypoglycaemia',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'Hypoglycaemia',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'ESRD end-stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'ESRD end-stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'American Diabetes Association (ADA',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'American Diabetes Association (ADA',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'carbohydrates',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'carbohydrates',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glucagon',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'glucagon',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '30',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '30',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '31',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '31',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '32',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '32',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Table 4',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'Table 4',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'N (%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'N (%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '11',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '71',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '71',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '20.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '20.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5 7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '5 7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '58.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '58.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '19 7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '19 7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '16 3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '16 3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '25.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '25.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '7 3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '7 3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '27.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '27.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '6 25',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '6 25',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '35.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '35.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '53',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '53',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3%',\n",
      "  'target_type': 'PERCENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '3%',\n",
      "  'source_type': 'PERCENT',\n",
      "  'target': '4.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '4.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1 2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '1 2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '16.7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': '16.7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2 2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '2 2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '7 1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': '7 1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '8.3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '8.3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1 0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': '1 0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': '0 6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '8.5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '8.5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': '0 1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1 1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': '1 1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3 2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': '3 2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '18.2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': '18.2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5 6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': '5 6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '10',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': '10',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Headache 2',\n",
      "  'target_type': 'EVENT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': 'Headache 2',\n",
      "  'source_type': 'EVENT',\n",
      "  'target': '6 0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': '6 0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': '0 5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '7.0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': '7.0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': '0 2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2 1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': '2 1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': '0 4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5.6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATS',\n",
      "  'source': '5.6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Administered before',\n",
      "  'source': '4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADD-ON TREATMENT',\n",
      "  'source': '0 3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3 0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MODIFIES',\n",
      "  'source': '3 0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '0 0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CO-OCCUR',\n",
      "  'source': '0 0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ASSOCIATED_WITH',\n",
      "  'source': '3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5 2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_LAB_VALUE',\n",
      "  'source': '5 2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2 0',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXPLORATORY_ENDPOINT',\n",
      "  'source': '2 0',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED TREATMENT',\n",
      "  'source': '7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '9.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EVALUATES_TREATMENT_EFFECT',\n",
      "  'source': '9.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2.8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Used for monitoring',\n",
      "  'source': '2.8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Reported',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'AE',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TRIAL_PERIOD',\n",
      "  'source': 'AE',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'AEs',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BETWEEN',\n",
      "  'source': 'AEs',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'American Diabetes Association',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIDE_EFFECT',\n",
      "  'source': 'American Diabetes Association',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'ADA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'REPRESENTED_BY',\n",
      "  'source': 'ADA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '22',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 83 nodes and 82 relationships.\n",
      "graph_21.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('symptomatic', 'DETAILED_DESCRIPTION'),\n",
      " ('hypoglycaemia', 'DISEASE_DISORDER'),\n",
      " ('plasma glucose concentration', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('B', 'LAB_VALUE'),\n",
      " ('3.9 mmol/L', 'LAB_VALUE'),\n",
      " ('70 mg/dL', 'LAB_VALUE'),\n",
      " ('hypo', 'SIGN_SYMPTOM'),\n",
      " ('glycaemia', 'DISEASE_DISORDER'),\n",
      " ('ADA classifi- cation', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('biochemically', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('plasma glucose', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('3.1 mmol/L', 'LAB_VALUE'),\n",
      " ('56 mg/dL', 'LAB_VALUE'),\n",
      " ('26-week', 'DATE'),\n",
      " ('-RENAL', 'DETAILED_DESCRIPTION'),\n",
      " ('moderate', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('liraglutide', 'MEDICATION'),\n",
      " ('renal function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('gastro', 'DISEASE_DISORDER'),\n",
      " ('in-', 'DETAILED_DESCRIPTION'),\n",
      " ('testinal', 'SIGN_SYMPTOM'),\n",
      " ('Minor increases', 'LAB_VALUE'),\n",
      " ('lipase levels', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('function', 'DETAILED_DESCRIPTION'),\n",
      " ('26', 'DATE'),\n",
      " ('week', 'DATE'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglu', 'MEDICATION'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('tide', 'MEDICATION'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('3.9', 'CARDINAL'),\n",
      " ('70', 'CARDINAL'),\n",
      " ('dL', 'PERSON'),\n",
      " ('ADA', 'ORG'),\n",
      " ('cation and/or biochemically', 'ORG'),\n",
      " ('3.1', 'CARDINAL'),\n",
      " ('56', 'CARDINAL'),\n",
      " ('1578', 'CARDINAL'),\n",
      " ('279', 'CARDINAL'),\n",
      " ('32', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('33', 'CARDINAL'),\n",
      " ('14', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'symptomatic',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'hypoglycaemia',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'hypoglycaemia',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'plasma glucose concentration',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'plasma glucose concentration',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'B',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'B',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '3.9 mmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': '3.9 mmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '70 mg/dL',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '70 mg/dL',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'hypo',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'hypo',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'glycaemia',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'glycaemia',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ADA classifi- cation',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'ADA classifi- cation',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'biochemically',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'biochemically',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'plasma glucose',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'plasma glucose',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '3.1 mmol/L',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': '3.1 mmol/L',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '56 mg/dL',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': '56 mg/dL',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '26-week',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '26-week',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '-RENAL',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': '-RENAL',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'moderate',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'moderate',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'liraglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'liraglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'gastro',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'gastro',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'in-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'in-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'testinal',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'testinal',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'Minor increases',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'Minor increases',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'lipase levels',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'lipase levels',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '26',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '26',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'week',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'week',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglu',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'semaglu',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'tide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'tide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '3.9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '3.9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '70',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '70',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'dL',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'dL',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'ADA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'ADA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'cation and/or biochemically',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'cation and/or biochemically',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '3.1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '3.1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '56',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '56',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1578',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '1578',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '279',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '279',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '32',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '32',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '33',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '33',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '14',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 46 nodes and 45 relationships.\n",
      "graph_22.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('renal', 'DISEASE_DISORDER'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('Renal impairment', 'DISEASE_DISORDER'),\n",
      " ('diabetes', 'DISEASE_DISORDER'),\n",
      " ('anti', 'MEDICATION'),\n",
      " ('glucagon', 'MEDICATION'),\n",
      " ('-like peptide-1 (GLP-1)', 'DETAILED_DESCRIPTION'),\n",
      " ('a- logue', 'DETAILED_DESCRIPTION'),\n",
      " ('94%', 'LAB_VALUE'),\n",
      " ('native human GLP-1', 'DETAILED_DESCRIPTION'),\n",
      " ('native GLP-1', 'DETAILED_DESCRIPTION'),\n",
      " ('aglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('amino', 'DETAILED_DESCRIPTION'),\n",
      " ('acid substitutions', 'SIGN_SYMPTOM'),\n",
      " ('position 8', 'DETAILED_DESCRIPTION'),\n",
      " ('alanine', 'DETAILED_DESCRIPTION'),\n",
      " ('a- aminoisobutyric acid', 'DETAILED_DESCRIPTION'),\n",
      " ('position 34', 'DETAILED_DESCRIPTION'),\n",
      " ('lysine to arginine', 'DETAILED_DESCRIPTION'),\n",
      " ('ac', 'DETAILED_DESCRIPTION'),\n",
      " ('ylation', 'SIGN_SYMPTOM'),\n",
      " ('lysine in position 26 with a spacer and C-18 fatty diacid chain',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('1', 'CARDINAL'),\n",
      " ('108', 'CARDINAL'),\n",
      " ('2860', 'DATE'),\n",
      " ('Søborg', 'ORG'),\n",
      " ('Denmark Clin Pharmacokinet', 'PERSON'),\n",
      " ('2018', 'DATE'),\n",
      " ('57:1571–1580', 'CARDINAL'),\n",
      " ('3', 'CARDINAL'),\n",
      " ('34', 'DATE'),\n",
      " ('26', 'CARDINAL'),\n",
      " ('C-18', 'PRODUCT'),\n",
      " ('4', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'Renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'anti',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'anti',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glucagon',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'glucagon',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-like peptide-1 (GLP-1)',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': '-like peptide-1 (GLP-1)',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'a- logue',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'a- logue',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '94%',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '94%',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'native human GLP-1',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'native human GLP-1',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'native GLP-1',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'native GLP-1',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'amino',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'amino',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'acid substitutions',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'acid substitutions',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'position 8',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'position 8',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'alanine',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'alanine',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'a- aminoisobutyric acid',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'a- aminoisobutyric acid',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'position 34',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'position 34',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'lysine to arginine',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'lysine to arginine',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ac',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'ac',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ylation',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'ylation',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'lysine in position 26 with a spacer and C-18 fatty diacid chain',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'lysine in position 26 with a spacer and C-18 fatty diacid chain',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '108',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '108',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2860',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '2860',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Søborg',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'Søborg',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Denmark Clin Pharmacokinet',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Denmark Clin Pharmacokinet',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2018',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '2018',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '57:1571–1580',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '57:1571–1580',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '34',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '34',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '26',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '26',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'C-18',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'C-18',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 36 nodes and 35 relationships.\n",
      "graph_23.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('longer-term', 'DETAILED_DESCRIPTION'),\n",
      " ('III', 'DETAILED_DESCRIPTION'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('sem', 'MEDICATION'),\n",
      " ('aglut', 'DETAILED_DESCRIPTION'),\n",
      " ('ide', 'MEDICATION'),\n",
      " ('GLP', 'MEDICATION'),\n",
      " ('-1 receptor agonists', 'DETAILED_DESCRIPTION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('aglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('type 2', 'DETAILED_DESCRIPTION'),\n",
      " ('diabetes', 'DISEASE_DISORDER'),\n",
      " ('moderate', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('pharma- cokinetics', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('clinic-based', 'DETAILED_DESCRIPTION'),\n",
      " ('multiple dosing', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('state', 'DETAILED_DESCRIPTION'),\n",
      " ('4–5 weeks', 'DATE'),\n",
      " ('glutide', 'DETAILED_DESCRIPTION'),\n",
      " ('normal renal', 'DETAILED_DESCRIPTION'),\n",
      " ('function', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('orally', 'DETAILED_DESCRIPTION'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('5–8', 'CARDINAL'),\n",
      " ('15', 'DATE'),\n",
      " ('34', 'CARDINAL'),\n",
      " ('PIONEER', 'ORG'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('11–12', 'CARDINAL'),\n",
      " ('29', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'longer-term',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'III',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'III',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'sem',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'sem',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'aglut',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'aglut',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'ide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'GLP',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'GLP',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-1 receptor agonists',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': '-1 receptor agonists',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'type 2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'type 2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'moderate',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'moderate',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'pharma- cokinetics',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'pharma- cokinetics',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'clinic-based',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'clinic-based',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'multiple dosing',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'multiple dosing',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'state',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'state',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '4–5 weeks',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '4–5 weeks',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'glutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'glutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'normal renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'normal renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'function',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'function',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'orally',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'orally',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '5–8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '5–8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '15',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '34',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '34',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'PIONEER',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'PIONEER',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11–12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '11–12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '29',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 33 nodes and 32 relationships.\n",
      "graph_24.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('orally administered', 'DETAILED_DESCRIPTION'),\n",
      " ('four', 'DETAILED_DESCRIPTION'),\n",
      " ('renal', 'DISEASE_DISORDER'),\n",
      " ('impairment', 'DETAILED_DESCRIPTION'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('normal renal function', 'DETAILED_DESCRIPTION'),\n",
      " ('respect to baseline characteristics', 'DETAILED_DESCRIPTION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('glut', 'MEDICATION'),\n",
      " ('D', 'DISEASE_DISORDER'),\n",
      " ('dialysis', 'DISEASE_DISORDER'),\n",
      " ('semaglut', 'MEDICATION'),\n",
      " ('AE', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('s', 'SIGN_SYMPTOM'),\n",
      " ('15', 'CARDINAL'),\n",
      " ('more than ten', 'CARDINAL'),\n",
      " ('18', 'CARDINAL'),\n",
      " ('19', 'CARDINAL'),\n",
      " ('5', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'orally administered',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'orally administered',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'four',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'four',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'normal renal function',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'normal renal function',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'respect to baseline characteristics',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'respect to baseline characteristics',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glut',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'glut',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'D',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'D',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'dialysis',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'dialysis',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'semaglut',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'semaglut',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'AE',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'AE',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 's',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 's',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '15',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'more than ten',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'more than ten',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '18',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '18',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '19',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '19',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 22 nodes and 21 relationships.\n",
      "graph_25.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Medical', 'DETAILED_DESCRIPTION'),\n",
      " ('Nordisk', 'DETAILED_DESCRIPTION'),\n",
      " ('́', 'DETAILED_DESCRIPTION'),\n",
      " ('nes', 'DETAILED_DESCRIPTION'),\n",
      " ('Pe ́terfy Sa ́ndor utcai', 'DETAILED_DESCRIPTION'),\n",
      " ('́rha ́z', 'DETAILED_DESCRIPTION'),\n",
      " ('Istva ́n Kiss', 'DETAILED_DESCRIPTION'),\n",
      " ('Szent Imre Egyetemi Oktato ́ko ́rha ́z', 'DETAILED_DESCRIPTION'),\n",
      " ('ra', 'DETAILED_DESCRIPTION'),\n",
      " ('ceutical Research Associates CZ', 'DETAILED_DESCRIPTION'),\n",
      " ('.r.o. Prague', 'DETAILED_DESCRIPTION'),\n",
      " ('usilova', 'DETAILED_DESCRIPTION'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('kova', 'DETAILED_DESCRIPTION'),\n",
      " ('Hemodialyzacˇnı ́ strˇedisko', 'DETAILED_DESCRIPTION'),\n",
      " ('Hradec Kra ́love ́-Novy ́ Hradec Kra ́love ́, Czech Republic',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('gaard', 'DETAILED_DESCRIPTION'),\n",
      " ('o Nordisk A/S', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('SNAC', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('analyses', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('s', 'DETAILED_DESCRIPTION'),\n",
      " ('Nordisk A/S', 'DETAILED_DESCRIPTION'),\n",
      " ('Andy Bond', 'PERSON'),\n",
      " ('Emma Marshman', 'PERSON'),\n",
      " ('Spirit Medical Communications Ltd', 'ORG'),\n",
      " ('Novo Nordisk', 'PERSON'),\n",
      " ('Ko´rha´z', 'PRODUCT'),\n",
      " ('Budapest', 'GPE'),\n",
      " ('Hungary', 'GPE'),\n",
      " ('Kiss', 'PERSON'),\n",
      " ('Szent Imre Egyetemi Oktato´ko´rha´z', 'PERSON'),\n",
      " ('Pharmaceutical Research Associates CZ', 'ORG'),\n",
      " ('Prague', 'GPE'),\n",
      " ('Czech Republic', 'GPE'),\n",
      " ('Sylvia Dusilova´-Sulkova', 'PERSON'),\n",
      " ('Hemodialyzacˇnı', 'PERSON'),\n",
      " ('Hradec Kra´love´-Novy´', 'PERSON'),\n",
      " ('Michael Pilgaard Andersen', 'PERSON'),\n",
      " ('Morten Donsmark', 'GPE'),\n",
      " ('Salvatore Calanna', 'PERSON')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Medical',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Nordisk',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'Nordisk',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '́',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': '́',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'nes',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'nes',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Pe ́terfy Sa ́ndor utcai',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'Pe ́terfy Sa ́ndor utcai',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '́rha ́z',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '́rha ́z',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Istva ́n Kiss',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'Istva ́n Kiss',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Szent Imre Egyetemi Oktato ́ko ́rha ́z',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'Szent Imre Egyetemi Oktato ́ko ́rha ́z',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ra',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'ra',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ceutical Research Associates CZ',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'ceutical Research Associates CZ',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '.r.o. Prague',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '.r.o. Prague',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'usilova',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'usilova',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'kova',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'kova',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Hemodialyzacˇnı ́ strˇedisko',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'Hemodialyzacˇnı ́ strˇedisko',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Hradec Kra ́love ́-Novy ́ Hradec Kra ́love ́, Czech Republic',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'Hradec Kra ́love ́-Novy ́ Hradec Kra ́love ́, Czech Republic',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'gaard',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'gaard',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'o Nordisk A/S',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'o Nordisk A/S',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'SNAC',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'SNAC',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'analyses',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'analyses',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 's',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 's',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Nordisk A/S',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'Nordisk A/S',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Andy Bond',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'Andy Bond',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Emma Marshman',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'Emma Marshman',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Spirit Medical Communications Ltd',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Spirit Medical Communications Ltd',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Novo Nordisk',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Novo Nordisk',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Ko´rha´z',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'Ko´rha´z',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': 'Budapest',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Budapest',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Hungary',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Hungary',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Kiss',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'Kiss',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Szent Imre Egyetemi Oktato´ko´rha´z',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'Szent Imre Egyetemi Oktato´ko´rha´z',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Pharmaceutical Research Associates CZ',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'Pharmaceutical Research Associates CZ',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Prague',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'Prague',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Czech Republic',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'Czech Republic',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Sylvia Dusilova´-Sulkova',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'Sylvia Dusilova´-Sulkova',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Hemodialyzacˇnı',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'Hemodialyzacˇnı',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Hradec Kra´love´-Novy´',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'Hradec Kra´love´-Novy´',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Michael Pilgaard Andersen',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Michael Pilgaard Andersen',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Morten Donsmark',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'Morten Donsmark',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Salvatore Calanna',\n",
      "  'target_type': 'PERSON'}]\n",
      "Graph created with 41 nodes and 40 relationships.\n",
      "graph_26.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Novo Nordisk A/S, Søborg, Denmark', 'DETAILED_DESCRIPTION'),\n",
      " ('A', 'DETAILED_DESCRIPTION'),\n",
      " ('Declaration', 'DETAILED_DESCRIPTION'),\n",
      " ('amendments', 'DETAILED_DESCRIPTION'),\n",
      " ('Novo Nordisk', 'ORG'),\n",
      " ('Søborg', 'ORG'),\n",
      " ('Denmark', 'GPE'),\n",
      " ('CG', 'PRODUCT'),\n",
      " ('FLS', 'ORG'),\n",
      " ('MT', 'ORG'),\n",
      " ('TWA', 'ORG'),\n",
      " ('the institutional and/or national research committee', 'ORG'),\n",
      " ('1964', 'DATE')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Novo Nordisk A/S, Søborg, Denmark',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'A',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'A',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Declaration',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'Declaration',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'amendments',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'amendments',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Novo Nordisk',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'Novo Nordisk',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Søborg',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'Søborg',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Denmark',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'Denmark',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'CG',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'CG',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': 'FLS',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'FLS',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'MT',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'MT',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'TWA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'TWA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'the institutional and/or national research committee',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'the institutional and/or national research committee',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1964',\n",
      "  'target_type': 'DATE'}]\n",
      "Graph created with 13 nodes and 12 relationships.\n",
      "graph_27.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Open', 'DETAILED_DESCRIPTION'),\n",
      " ('Attribution-NonCommercial 4.0 International', 'DETAILED_DESCRIPTION'),\n",
      " ('type 2 dia- betes', 'DISEASE_DISORDER'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('Glucose', 'MEDICATION'),\n",
      " ('-lowering', 'DETAILED_DESCRIPTION'),\n",
      " ('chronic', 'DETAILED_DESCRIPTION'),\n",
      " ('kidney disease', 'DISEASE_DISORDER'),\n",
      " ('Semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('once-weekly human GLP-1 analog', 'DETAILED_DESCRIPTION'),\n",
      " ('Oral Semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('Renal Impairment 1579', 'DETAILED_DESCRIPTION'),\n",
      " ('combined oral contraceptive', 'DETAILED_DESCRIPTION'),\n",
      " ('ethinylestradiol/levonorgestrel', 'DETAILED_DESCRIPTION'),\n",
      " ('once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('once-weekly', 'DETAILED_DESCRIPTION'),\n",
      " ('monotherapy', 'DETAILED_DESCRIPTION'),\n",
      " ('type', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('double-blind', 'DETAILED_DESCRIPTION'),\n",
      " ('randomised, placebo-controlled,', 'DETAILED_DESCRIPTION'),\n",
      " ('parallel-group, multinational, multicentre', 'DETAILED_DESCRIPTION'),\n",
      " ('the Creative Commons Attribution-NonCommercial 4.0 International License',\n",
      "  'ORG'),\n",
      " ('the Creative Commons', 'ORG'),\n",
      " ('1', 'CARDINAL'),\n",
      " ('Chatterjee S', 'PERSON'),\n",
      " ('Khunti K.', 'PERSON'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('Clin Pharmacol', 'PERSON'),\n",
      " ('2016;8:61–81', 'CARDINAL'),\n",
      " ('Nephrol Dial Transpl', 'ORG'),\n",
      " ('2014;29(7):1284–300', 'CARDINAL'),\n",
      " ('3', 'CARDINAL'),\n",
      " ('Kapitza C', 'PERSON'),\n",
      " ('Nosek L', 'PERSON'),\n",
      " ('Jensen L', 'PERSON'),\n",
      " ('Hartvig H', 'ORG'),\n",
      " ('Jensen CB', 'PERSON'),\n",
      " ('Flint A. Semaglutide', 'PERSON'),\n",
      " ('weekly', 'DATE'),\n",
      " ('GLP-1', 'PERSON'),\n",
      " ('Pharmacokinetics, Safety and Tolerability of Oral Semaglutide', 'ORG'),\n",
      " ('1579reduce', 'CARDINAL'),\n",
      " ('2015;55(5):497–504.', 'DATE'),\n",
      " ('2015;58(18):7370–80.', 'DATE'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('Sorli C', 'PERSON'),\n",
      " ('Tsoukas GM', 'ORG'),\n",
      " ('al. Efﬁcacy', 'ORG'),\n",
      " ('3a', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Open',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Attribution-NonCommercial 4.0 International',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'Attribution-NonCommercial 4.0 International',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'type 2 dia- betes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'type 2 dia- betes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Glucose',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'Glucose',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-lowering',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '-lowering',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'chronic',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'chronic',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'kidney disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'kidney disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'Semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'once-weekly human GLP-1 analog',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'once-weekly human GLP-1 analog',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Oral Semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'Oral Semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Renal Impairment 1579',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'Renal Impairment 1579',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'combined oral contraceptive',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'combined oral contraceptive',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ethinylestradiol/levonorgestrel',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'ethinylestradiol/levonorgestrel',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'once-weekly',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'once-weekly',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'monotherapy',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'monotherapy',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'type',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'type',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'double-blind',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'double-blind',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'randomised, placebo-controlled,',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'randomised, placebo-controlled,',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'parallel-group, multinational, multicentre',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'parallel-group, multinational, multicentre',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'the Creative Commons Attribution-NonCommercial 4.0 International '\n",
      "            'License',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'the Creative Commons Attribution-NonCommercial 4.0 International '\n",
      "            'License',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'the Creative Commons',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'the Creative Commons',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '1',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Chatterjee S',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Chatterjee S',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Khunti K.',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Khunti K.',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Clin Pharmacol',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Clin Pharmacol',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2016;8:61–81',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '2016;8:61–81',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Nephrol Dial Transpl',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'Nephrol Dial Transpl',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2014;29(7):1284–300',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '2014;29(7):1284–300',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '3',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Kapitza C',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'Kapitza C',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Nosek L',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'Nosek L',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Jensen L',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'Jensen L',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Hartvig H',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'Hartvig H',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Jensen CB',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'Jensen CB',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Flint A. Semaglutide',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Flint A. Semaglutide',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'weekly',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'weekly',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Pharmacokinetics, Safety and Tolerability of Oral Semaglutide',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'Pharmacokinetics, Safety and Tolerability of Oral Semaglutide',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1579reduce',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '1579reduce',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2015;55(5):497–504.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '2015;55(5):497–504.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '2015;58(18):7370–80.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '2015;58(18):7370–80.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '5',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': '5',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Sorli C',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'Sorli C',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Tsoukas GM',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'Tsoukas GM',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'al. Efﬁcacy',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'al. Efﬁcacy',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '3a',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 50 nodes and 49 relationships.\n",
      "graph_28.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('once', 'DOSAGE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('weekly', 'DOSAGE'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('daily', 'DOSAGE'),\n",
      " ('sitagliptin', 'MEDICATION'),\n",
      " ('metformin', 'MEDICATION'),\n",
      " ('thiazolidinediones', 'MEDICATION'),\n",
      " ('type', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('56', 'DURATION'),\n",
      " ('week', 'DATE'),\n",
      " ('double-blind', 'DETAILED_DESCRIPTION'),\n",
      " ('once- weekly', 'DOSAGE'),\n",
      " ('insulin glargine', 'MEDICATION'),\n",
      " ('sulfonylureas', 'DETAILED_DESCRIPTION'),\n",
      " ('-naive', 'DETAILED_DESCRIPTION'),\n",
      " ('type 2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('open- label', 'DETAILED_DESCRIPTION'),\n",
      " ('parallel-group', 'DETAILED_DESCRIPTION'),\n",
      " ('multicentre', 'DETAILED_DESCRIPTION'),\n",
      " ('exenatide ER', 'MEDICATION'),\n",
      " ('open-label', 'DETAILED_DESCRIPTION'),\n",
      " ('Lancet Diabetes Endocrinol', 'PERSON'),\n",
      " ('2017;5(4):251–60. 6', 'DATE'),\n",
      " ('Masmiquel L', 'PERSON'),\n",
      " ('Kumar H', 'PERSON'),\n",
      " ('al.', 'ORG'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('56-week', 'DATE'),\n",
      " ('3a', 'CARDINAL'),\n",
      " ('2017;5(5):341–54', 'CARDINAL'),\n",
      " ('7', 'CARDINAL'),\n",
      " ('Aroda VR', 'PERSON'),\n",
      " ('Bain SC', 'ORG'),\n",
      " ('Cariou B', 'PERSON'),\n",
      " ('4', 'CARDINAL'),\n",
      " ('8', 'CARDINAL'),\n",
      " ('Ahmann AJ', 'ORG'),\n",
      " ('Capehorn M', 'ORG'),\n",
      " ('Charpentier G', 'PERSON'),\n",
      " ('ER', 'ORG'),\n",
      " ('3', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'once',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'weekly',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'weekly',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'daily',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'daily',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'sitagliptin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'sitagliptin',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'metformin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'metformin',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'thiazolidinediones',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'thiazolidinediones',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'type',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'type',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '56',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '56',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'week',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'week',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'double-blind',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'double-blind',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'once- weekly',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'once- weekly',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'insulin glargine',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'insulin glargine',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'sulfonylureas',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'sulfonylureas',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '-naive',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '-naive',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'type 2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'type 2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'open- label',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'open- label',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'parallel-group',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'parallel-group',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'multicentre',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'multicentre',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'exenatide ER',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'exenatide ER',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'open-label',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'open-label',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Lancet Diabetes Endocrinol',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'Lancet Diabetes Endocrinol',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017;5(4):251–60. 6',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '2017;5(4):251–60. 6',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Masmiquel L',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Masmiquel L',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Kumar H',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Kumar H',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'al.',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'al.',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '56-week',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '56-week',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '3a',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '3a',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2017;5(5):341–54',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': '2017;5(5):341–54',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '7',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '7',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Aroda VR',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'Aroda VR',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Bain SC',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'Bain SC',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Cariou B',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'Cariou B',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Ahmann AJ',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Ahmann AJ',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Capehorn M',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'Capehorn M',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Charpentier G',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'Charpentier G',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'ER',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'ER',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '3',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 43 nodes and 42 relationships.\n",
      "graph_29.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('Semaglutide', 'MEDICATION'),\n",
      " ('cardio- vascular', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('type', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('oral delivery', 'DETAILED_DESCRIPTION'),\n",
      " ('peptide', 'DETAILED_DESCRIPTION'),\n",
      " ('protein drugs', 'DETAILED_DESCRIPTION'),\n",
      " ('Glucagon-like peptide-1', 'DETAILED_DESCRIPTION'),\n",
      " ('class B G protein-coupled receptors', 'DETAILED_DESCRIPTION'),\n",
      " ('oral formulation', 'DETAILED_DESCRIPTION'),\n",
      " ('aglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('glycemic control', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('single', 'DETAILED_DESCRIPTION'),\n",
      " ('human glucagon-like peptide-1 analog', 'DETAILED_DESCRIPTION'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('creatinine clearance', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('creatinine', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('2018;41(2):258–66.', 'DATE'),\n",
      " ('9', 'CARDINAL'),\n",
      " ('Marso SP', 'ORG'),\n",
      " ('Bain SC', 'ORG'),\n",
      " ('Consoli A', 'PERSON'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('N Engl J Med', 'ORG'),\n",
      " ('2016;375(19):1834–44', 'DATE'),\n",
      " ('10', 'CARDINAL'),\n",
      " ('Mahato RI', 'PERSON'),\n",
      " ('Narang AS', 'PERSON'),\n",
      " ('Thoma L', 'ORG'),\n",
      " ('Crit Rev Ther Drug Carrier Syst', 'ORG'),\n",
      " ('2003;20(2–3):153–214. 11', 'DATE'),\n",
      " ('Graaf', 'PERSON'),\n",
      " ('al', 'PERSON'),\n",
      " ('Glucagon', 'PERSON'),\n",
      " ('2016;68(4):954–1013', 'CARDINAL'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('Buckley ST', 'PERSON'),\n",
      " ('SG', 'ORG'),\n",
      " ('Kirk RK', 'PERSON'),\n",
      " ('Knudsen LB', 'PERSON'),\n",
      " ('2017;66(Suppl', 'CARDINAL'),\n",
      " ('13', 'CARDINAL'),\n",
      " ('Connor A', 'PERSON'),\n",
      " ('14', 'CARDINAL'),\n",
      " ('Davies M', 'ORG'),\n",
      " ('Hartoft-Nielsen M-L', 'PERSON'),\n",
      " ('Hansen OKH', 'PERSON'),\n",
      " ('JAMA', 'PERSON'),\n",
      " ('2017;318(15):1460–70.', 'DATE'),\n",
      " ('15', 'CARDINAL'),\n",
      " ('Flint A', 'ORG'),\n",
      " ('Jacobsen JB', 'PERSON'),\n",
      " ('Lasseter K. Pharmacokinetics', 'PERSON'),\n",
      " ('Clin Pharmacokinet', 'PERSON'),\n",
      " ('2017;56(11):1381–90', 'CARDINAL'),\n",
      " ('16', 'CARDINAL'),\n",
      " ('Cockcroft DW', 'PERSON'),\n",
      " ('Gault MH', 'ORG'),\n",
      " ('serum creatinine', 'ORG'),\n",
      " ('Nephron', 'ORG'),\n",
      " ('1976;16(1):31–41. 17', 'DATE'),\n",
      " ('DuBois EF', 'ORG')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'Semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'cardio- vascular',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'cardio- vascular',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'type',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'type',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'oral delivery',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'oral delivery',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'peptide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'peptide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'protein drugs',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'protein drugs',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Glucagon-like peptide-1',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'Glucagon-like peptide-1',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'class B G protein-coupled receptors',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'class B G protein-coupled receptors',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'oral formulation',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'oral formulation',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glycemic control',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'glycemic control',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'single',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'single',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'human glucagon-like peptide-1 analog',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'human glucagon-like peptide-1 analog',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'creatinine clearance',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'creatinine clearance',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'creatinine',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'creatinine',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '2018;41(2):258–66.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': '2018;41(2):258–66.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Marso SP',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'Marso SP',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Bain SC',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'Bain SC',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Consoli A',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'Consoli A',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'N Engl J Med',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'N Engl J Med',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2016;375(19):1834–44',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '2016;375(19):1834–44',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '10',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '10',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Mahato RI',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Mahato RI',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Narang AS',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Narang AS',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Thoma L',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'Thoma L',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Crit Rev Ther Drug Carrier Syst',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'Crit Rev Ther Drug Carrier Syst',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2003;20(2–3):153–214. 11',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '2003;20(2–3):153–214. 11',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Graaf',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'Graaf',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'al',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'al',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Glucagon',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'Glucagon',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2016;68(4):954–1013',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '2016;68(4):954–1013',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Buckley ST',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Buckley ST',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'SG',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'SG',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Kirk RK',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'Kirk RK',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Knudsen LB',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'Knudsen LB',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017;66(Suppl',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '2017;66(Suppl',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '13',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '13',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Connor A',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'Connor A',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '14',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': '14',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Davies M',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'Davies M',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Hartoft-Nielsen M-L',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'Hartoft-Nielsen M-L',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Hansen OKH',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'Hansen OKH',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'JAMA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': 'JAMA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017;318(15):1460–70.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': '2017;318(15):1460–70.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '15',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Flint A',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': 'Flint A',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Jacobsen JB',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': 'Jacobsen JB',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Lasseter K. Pharmacokinetics',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': 'Lasseter K. Pharmacokinetics',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Clin Pharmacokinet',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': 'Clin Pharmacokinet',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017;56(11):1381–90',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': '2017;56(11):1381–90',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '16',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': '16',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Cockcroft DW',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': 'Cockcroft DW',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Gault MH',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': 'Gault MH',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'serum creatinine',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': 'serum creatinine',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Nephron',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': 'Nephron',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '1976;16(1):31–41. 17',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '1976;16(1):31–41. 17',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'DuBois EF',\n",
      "  'target_type': 'ORG'}]\n",
      "Graph created with 64 nodes and 63 relationships.\n",
      "graph_30.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('surface area', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('renal function', 'DISEASE_DISORDER'),\n",
      " ('single escalating doses', 'DETAILED_DESCRIPTION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('male', 'DETAILED_DESCRIPTION'),\n",
      " ('glomerular filtration rate', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('serum', 'DETAILED_DESCRIPTION'),\n",
      " ('creatinine', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Diet', 'HISTORY'),\n",
      " ('Renal', 'DISEASE_DISORDER'),\n",
      " ('Hypoglycemia', 'DISEASE_DISORDER'),\n",
      " ('Arch Intern Med', 'PERSON'),\n",
      " ('18', 'CARDINAL'),\n",
      " ('European Medicines Agency', 'ORG'),\n",
      " ('2004.http://www.ema.europa.eu/', 'CARDINAL'),\n",
      " ('Scientiﬁc_guideline/2009/09/', 'ORG'),\n",
      " ('Nov 2017', 'DATE'),\n",
      " ('19', 'CARDINAL'),\n",
      " ('US Food and Drug Administration', 'ORG'),\n",
      " ('Center for Drug Evaluation and Research', 'ORG'),\n",
      " ('Draft Guidance', 'PERSON'),\n",
      " ('2010', 'DATE'),\n",
      " ('Revision 1', 'LAW'),\n",
      " ('20', 'CARDINAL'),\n",
      " ('Bækdal TA', 'PERSON'),\n",
      " ('Blicher TM', 'ORG'),\n",
      " ('Donsmark M', 'ORG'),\n",
      " ('2017;66(Suppl', 'CARDINAL'),\n",
      " ('21', 'CARDINAL'),\n",
      " ('Bosch JP', 'PERSON'),\n",
      " ('Lewis JB', 'PERSON'),\n",
      " ('al', 'PERSON'),\n",
      " ('Renal Disease Study Group', 'ORG'),\n",
      " ('Ann Intern Med', 'PERSON'),\n",
      " ('1999;130(6):461–70.', 'DATE'),\n",
      " ('22', 'CARDINAL'),\n",
      " ('Seaquist ER', 'PERSON'),\n",
      " ('Anderson J', 'PERSON'),\n",
      " ('the American Diabetes Association', 'ORG'),\n",
      " ('the Endocrine Society', 'ORG')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'surface area',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'renal function',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'renal function',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'single escalating doses',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'single escalating doses',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'male',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'male',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'glomerular filtration rate',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'glomerular filtration rate',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'serum',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'serum',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'creatinine',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'creatinine',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Diet',\n",
      "  'target_type': 'HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'Diet',\n",
      "  'source_type': 'HISTORY',\n",
      "  'target': 'Renal',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'Renal',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Hypoglycemia',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'Hypoglycemia',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Arch Intern Med',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'Arch Intern Med',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '18',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '18',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'European Medicines Agency',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'European Medicines Agency',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2004.http://www.ema.europa.eu/',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '2004.http://www.ema.europa.eu/',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Scientiﬁc_guideline/2009/09/',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'Scientiﬁc_guideline/2009/09/',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Nov 2017',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'Nov 2017',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '19',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '19',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'US Food and Drug Administration',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'US Food and Drug Administration',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Center for Drug Evaluation and Research',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Center for Drug Evaluation and Research',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Draft Guidance',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'Draft Guidance',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2010',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '2010',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'Revision 1',\n",
      "  'target_type': 'LAW'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'Revision 1',\n",
      "  'source_type': 'LAW',\n",
      "  'target': '20',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '20',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Bækdal TA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Bækdal TA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Blicher TM',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Blicher TM',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Donsmark M',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'Donsmark M',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2017;66(Suppl',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '2017;66(Suppl',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '21',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '21',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Bosch JP',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'Bosch JP',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Lewis JB',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'Lewis JB',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'al',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'al',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Renal Disease Study Group',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'Renal Disease Study Group',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Ann Intern Med',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'Ann Intern Med',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '1999;130(6):461–70.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '1999;130(6):461–70.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '22',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '22',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Seaquist ER',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'Seaquist ER',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Anderson J',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Anderson J',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'the American Diabetes Association',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'the American Diabetes Association',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'the Endocrine Society',\n",
      "  'target_type': 'ORG'}]\n",
      "Graph created with 41 nodes and 40 relationships.\n",
      "graph_31.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('1', 'LAB_VALUE'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('-1 analogue liraglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('lira', 'MEDICATION'),\n",
      " ('glutide', 'DETAILED_DESCRIPTION'),\n",
      " ('once weekly', 'DETAILED_DESCRIPTION'),\n",
      " ('dulaglutide', 'MEDICATION'),\n",
      " ('albiglutide', 'MEDICATION'),\n",
      " ('lixisenatide', 'MEDICATION'),\n",
      " ('type', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('-1 analogue semaglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('plasma glucose', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('plasma', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('liraglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('2 diabetes mellitus', 'DISEASE_DISORDER'),\n",
      " ('end', 'DETAILED_DESCRIPTION'),\n",
      " ('stage renal disease', 'DISEASE_DISORDER'),\n",
      " ('Incretin', 'MEDICATION'),\n",
      " ('glucagon', 'MEDICATION'),\n",
      " ('-like peptide-1 receptor agonists', 'DETAILED_DESCRIPTION'),\n",
      " ('dipeptidyl peptidase-4 inhibitors', 'DETAILED_DESCRIPTION'),\n",
      " ('2013;36(5):1384–95', 'CARDINAL'),\n",
      " ('23', 'CARDINAL'),\n",
      " ('Jacobsen LV', 'PERSON'),\n",
      " ('Hindsberger C', 'ORG'),\n",
      " ('Zdravkovic M. Effect', 'PERSON'),\n",
      " ('GLP-1', 'LOC'),\n",
      " ('Br J Clin Pharmacol', 'PERSON'),\n",
      " ('2009;68(6):898–905', 'CARDINAL'),\n",
      " ('24', 'CARDINAL'),\n",
      " ('Davidson JA', 'PERSON'),\n",
      " ('Brett J, Falahati A', 'ORG'),\n",
      " ('Scott D. Mild', 'PERSON'),\n",
      " ('2011;17(3):345–55', 'CARDINAL'),\n",
      " ('25', 'CARDINAL'),\n",
      " ('Loghin C', 'PERSON'),\n",
      " ('Cui X', 'PERSON'),\n",
      " ('Zhang X', 'PERSON'),\n",
      " ('Chien JY', 'PERSON'),\n",
      " ('weekly', 'DATE'),\n",
      " ('857', 'CARDINAL'),\n",
      " ('Diabetologia', 'PERSON'),\n",
      " ('1):S349', 'DATE'),\n",
      " ('26', 'CARDINAL'),\n",
      " ('MA', 'PERSON'),\n",
      " ('Wald JA', 'PERSON'),\n",
      " ('Matthews JE', 'ORG'),\n",
      " ('Yang F, Reinhardt RR', 'PERSON'),\n",
      " ('Postgrad Med', 'PERSON'),\n",
      " ('2014;126(3):35–46', 'ORG'),\n",
      " ('27', 'CARDINAL'),\n",
      " ('Hanefeld M', 'ORG'),\n",
      " ('Leiter LA', 'PERSON'),\n",
      " ('al.', 'ORG'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('Obes Metab', 'PERSON'),\n",
      " ('2017;19(11):1594–601', 'CARDINAL'),\n",
      " ('28', 'CARDINAL'),\n",
      " ('Jensen L', 'PERSON'),\n",
      " ('Helleberg H', 'ORG'),\n",
      " ('Roffel A', 'PERSON'),\n",
      " ('2017;104:31–41.', 'DATE'),\n",
      " ('29', 'CARDINAL'),\n",
      " ('Osonoi', 'PERSON'),\n",
      " ('Saito M', 'PERSON'),\n",
      " ('Tamasawa A', 'ORG'),\n",
      " ('PLoS', 'PERSON'),\n",
      " ('One', 'CARDINAL'),\n",
      " ('2014;9(12):e113468.', 'DATE'),\n",
      " ('30', 'CARDINAL'),\n",
      " ('Nauck M. Incretin', 'PERSON')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': '1',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '-1 analogue liraglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': '-1 analogue liraglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'lira',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'lira',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'glutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'once weekly',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'once weekly',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'dulaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'dulaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'albiglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'albiglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'lixisenatide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'lixisenatide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'type',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'type',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '-1 analogue semaglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': '-1 analogue semaglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'plasma glucose',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'plasma glucose',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'plasma',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'plasma',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'liraglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'liraglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '2 diabetes mellitus',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '2 diabetes mellitus',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'end',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'end',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'stage renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'stage renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'Incretin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'Incretin',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glucagon',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'glucagon',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-like peptide-1 receptor agonists',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '-like peptide-1 receptor agonists',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'dipeptidyl peptidase-4 inhibitors',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'dipeptidyl peptidase-4 inhibitors',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2013;36(5):1384–95',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '2013;36(5):1384–95',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '23',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '23',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Jacobsen LV',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'Jacobsen LV',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Hindsberger C',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'Hindsberger C',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Zdravkovic M. Effect',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'Zdravkovic M. Effect',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'LOC'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'LOC',\n",
      "  'target': 'Br J Clin Pharmacol',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Br J Clin Pharmacol',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2009;68(6):898–905',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '2009;68(6):898–905',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '24',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '24',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Davidson JA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'Davidson JA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Brett J, Falahati A',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'Brett J, Falahati A',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Scott D. Mild',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'Scott D. Mild',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2011;17(3):345–55',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '2011;17(3):345–55',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '25',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '25',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Loghin C',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'Loghin C',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Cui X',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'Cui X',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Zhang X',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'Zhang X',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Chien JY',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'Chien JY',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'weekly',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'weekly',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '857',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '857',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Diabetologia',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'Diabetologia',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '1):S349',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '1):S349',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '26',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': '26',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'MA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'MA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Wald JA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'Wald JA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Matthews JE',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'Matthews JE',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Yang F, Reinhardt RR',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': 'Yang F, Reinhardt RR',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Postgrad Med',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': 'Postgrad Med',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2014;126(3):35–46',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': '2014;126(3):35–46',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '27',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '27',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Hanefeld M',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': 'Hanefeld M',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Leiter LA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': 'Leiter LA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'al.',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PROGRESSION TO',\n",
      "  'source': 'al.',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PRESENTED_AT',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Obes Metab',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSED',\n",
      "  'source': 'Obes Metab',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017;19(11):1594–601',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_HIGHER_ADVERSE_EVENTS_THAN',\n",
      "  'source': '2017;19(11):1594–601',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '28',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Causes',\n",
      "  'source': '28',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Jensen L',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVES',\n",
      "  'source': 'Jensen L',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Helleberg H',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NONINFERIORITY',\n",
      "  'source': 'Helleberg H',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Roffel A',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Holding a patent for',\n",
      "  'source': 'Roffel A',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017;104:31–41.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMBINED_WITH',\n",
      "  'source': '2017;104:31–41.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '29',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION',\n",
      "  'source': '29',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Osonoi',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EFFECTS_ON',\n",
      "  'source': 'Osonoi',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Saito M',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSAGE',\n",
      "  'source': 'Saito M',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Tamasawa A',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATS',\n",
      "  'source': 'Tamasawa A',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'PLoS',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Administered before',\n",
      "  'source': 'PLoS',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'One',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADD-ON TREATMENT',\n",
      "  'source': 'One',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2014;9(12):e113468.',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MODIFIES',\n",
      "  'source': '2014;9(12):e113468.',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '30',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CO-OCCUR',\n",
      "  'source': '30',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Nauck M. Incretin',\n",
      "  'target_type': 'PERSON'}]\n",
      "Graph created with 72 nodes and 71 relationships.\n",
      "graph_32.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('es', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('once', 'DOSAGE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('weekly', 'DOSAGE'),\n",
      " ('GLP-1 receptor agonist', 'DETAILED_DESCRIPTION'),\n",
      " ('al', 'MEDICATION'),\n",
      " ('biglutide', 'DETAILED_DESCRIPTION'),\n",
      " ('sitagliptin', 'MEDICATION'),\n",
      " ('type', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('ran- domized', 'DETAILED_DESCRIPTION'),\n",
      " ('III', 'DETAILED_DESCRIPTION'),\n",
      " ('liraglutide', 'MEDICATION'),\n",
      " ('glucose-lowering', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('type 2', 'DETAILED_DESCRIPTION'),\n",
      " ('diabetes', 'DISEASE_DISORDER'),\n",
      " ('moderate renal', 'DETAILED_DESCRIPTION'),\n",
      " ('impairment', 'DISEASE_DISORDER'),\n",
      " ('IRA-RENAL', 'DETAILED_DESCRIPTION'),\n",
      " ('Amylase', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('lipase', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('acute', 'DETAILED_DESCRIPTION'),\n",
      " ('pancreatitis', 'SIGN_SYMPTOM'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('hepatic impairment', 'DISEASE_DISORDER'),\n",
      " ('2016;18(3):203–16', 'DATE'),\n",
      " ('31', 'CARDINAL'),\n",
      " ('Leiter LA', 'PERSON'),\n",
      " ('Carr MC', 'ORG'),\n",
      " ('Stewart M', 'PERSON'),\n",
      " ('al.', 'ORG'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('2014;37(10):2723–30', 'CARDINAL'),\n",
      " ('32', 'CARDINAL'),\n",
      " ('Bain SC', 'ORG'),\n",
      " ('Atkin SL', 'FAC'),\n",
      " ('2016;39(2):222–30', 'CARDINAL'),\n",
      " ('33', 'CARDINAL'),\n",
      " ('Steinberg', 'PERSON'),\n",
      " ('Buse JB', 'PERSON'),\n",
      " ('Ghorbani MLM', 'PERSON'),\n",
      " ('DD', 'GPE'),\n",
      " ('Nauck MA', 'ORG'),\n",
      " ('LEADER Steering Committee', 'ORG'),\n",
      " ('LEADER', 'ORG'),\n",
      " ('2017;40(7):966–72', 'CARDINAL'),\n",
      " ('34', 'CARDINAL'),\n",
      " ('Jensen L', 'PERSON'),\n",
      " ('Kupcova V', 'PERSON'),\n",
      " ('Arold G', 'PERSON'),\n",
      " ('2017', 'DATE'),\n",
      " ('1580', 'DATE'),\n",
      " ('C. Granhall et al', 'PERSON')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'es',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'once',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'once',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'weekly',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'weekly',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'GLP-1 receptor agonist',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'GLP-1 receptor agonist',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'al',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'al',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'biglutide',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'biglutide',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'sitagliptin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'sitagliptin',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'type',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'type',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ran- domized',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'ran- domized',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'III',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'III',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'liraglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'liraglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glucose-lowering',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'glucose-lowering',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'type 2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'type 2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'moderate renal',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'moderate renal',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'IRA-RENAL',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'IRA-RENAL',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Amylase',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Amylase',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'lipase',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'lipase',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'acute',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'acute',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'pancreatitis',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'pancreatitis',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'hepatic impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'hepatic impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '2016;18(3):203–16',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '2016;18(3):203–16',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '31',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '31',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Leiter LA',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'Leiter LA',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Carr MC',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Carr MC',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Stewart M',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'Stewart M',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'al.',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'al.',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2014;37(10):2723–30',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': '2014;37(10):2723–30',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '32',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '32',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Bain SC',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'Bain SC',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Atkin SL',\n",
      "  'target_type': 'FAC'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'Atkin SL',\n",
      "  'source_type': 'FAC',\n",
      "  'target': '2016;39(2):222–30',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '2016;39(2):222–30',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '33',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '33',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Steinberg',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'Steinberg',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Buse JB',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'Buse JB',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Ghorbani MLM',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'Ghorbani MLM',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'DD',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'DD',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Nauck MA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'Nauck MA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'LEADER Steering Committee',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'LEADER Steering Committee',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'LEADER',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'LEADER',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '2017;40(7):966–72',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': '2017;40(7):966–72',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '34',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '34',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Jensen L',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': 'Jensen L',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Kupcova V',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': 'Kupcova V',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'Arold G',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': 'Arold G',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '2017',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXCLUSION_CRITERIA',\n",
      "  'source': '2017',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '1580',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE',\n",
      "  'source': '1580',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'C. Granhall et al',\n",
      "  'target_type': 'PERSON'}]\n",
      "Graph created with 55 nodes and 54 relationships.\n",
      "graph_33.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('position 8', 'DETAILED_DESCRIPTION'),\n",
      " ('aglutide', 'SIGN_SYMPTOM'),\n",
      " ('dipeptidyl peptidase-4 (DPP-4', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('lysine ac', 'DETAILED_DESCRIPTION'),\n",
      " ('ylation', 'SIGN_SYMPTOM'),\n",
      " ('albumin', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('type', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('once-weekly subcutaneous administration', 'DOSAGE'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('glycaemic control', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('reduce', 'LAB_VALUE'),\n",
      " ('body weight', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('sitagliptin', 'MEDICATION'),\n",
      " ('extended-release', 'DETAILED_DESCRIPTION'),\n",
      " ('exenatide', 'MEDICATION'),\n",
      " ('insulin glargine', 'MEDICATION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('antidiabetic drugs', 'MEDICATION'),\n",
      " ('once', 'DOSAGE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('weekly subcutaneous', 'DOSAGE'),\n",
      " ('cardiovascular events', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('peptide-based', 'DETAILED_DESCRIPTION'),\n",
      " ('GLP', 'MEDICATION'),\n",
      " ('-1 receptor agonists', 'DETAILED_DESCRIPTION'),\n",
      " ('8', 'CARDINAL'),\n",
      " ('dipeptidyl peptidase-4', 'PERSON'),\n",
      " ('DPP-4', 'ORG'),\n",
      " ('4', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('weekly', 'DATE'),\n",
      " ('5–8', 'CARDINAL'),\n",
      " ('9', 'CARDINAL'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('10', 'CARDINAL'),\n",
      " ('11', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'position 8',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'dipeptidyl peptidase-4 (DPP-4',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'dipeptidyl peptidase-4 (DPP-4',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'lysine ac',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'lysine ac',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'ylation',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'ylation',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'albumin',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'albumin',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'type',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'type',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'once-weekly subcutaneous administration',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'once-weekly subcutaneous administration',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'glycaemic control',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'glycaemic control',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'reduce',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'reduce',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'body weight',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'body weight',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'sitagliptin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'sitagliptin',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'extended-release',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'extended-release',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'exenatide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'exenatide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'insulin glargine',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'insulin glargine',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'antidiabetic drugs',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'antidiabetic drugs',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'once',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'once',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'weekly subcutaneous',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'weekly subcutaneous',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'cardiovascular events',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'cardiovascular events',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'peptide-based',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'peptide-based',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'GLP',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'GLP',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-1 receptor agonists',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '-1 receptor agonists',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'dipeptidyl peptidase-4',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'dipeptidyl peptidase-4',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': 'DPP-4',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'DPP-4',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '4',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '4',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'weekly',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'weekly',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '5–8',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': '5–8',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '9',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '9',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'GLP-1',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'GLP-1',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '10',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '10',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '11',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 37 nodes and 36 relationships.\n",
      "graph_34.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('-form', 'DETAILED_DESCRIPTION'),\n",
      " ('enhancer', 'DETAILED_DESCRIPTION'),\n",
      " ('Oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('-formulation', 'DETAILED_DESCRIPTION'),\n",
      " ('absorption enhancer sodiumN-(8-[2-hydroxy- benzoyl] amino) caprylate (SNAC',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('gastric', 'BIOLOGICAL_STRUCTURE'),\n",
      " ('Once-daily', 'DOSAGE'),\n",
      " ('better', 'LAB_VALUE'),\n",
      " ('glycaemic control', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('reductions', 'SIGN_SYMPTOM'),\n",
      " ('body weight', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('26', 'DATE'),\n",
      " ('-', 'DETAILED_DESCRIPTION'),\n",
      " ('week', 'DATE'),\n",
      " ('II', 'DETAILED_DESCRIPTION'),\n",
      " ('–response', 'DETAILED_DESCRIPTION'),\n",
      " ('2 diabetes', 'DISEASE_DISORDER'),\n",
      " ('proteolytic cleavage', 'DETAILED_DESCRIPTION'),\n",
      " ('peptide backbone', 'DETAILED_DESCRIPTION'),\n",
      " ('sequential b-oxidation', 'DETAILED_DESCRIPTION'),\n",
      " ('fatty acid side chain', 'DETAILED_DESCRIPTION'),\n",
      " ('subcutaneous', 'DETAILED_DESCRIPTION'),\n",
      " ('12', 'CARDINAL'),\n",
      " ('13', 'CARDINAL'),\n",
      " ('26-week', 'DATE'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('14', 'CARDINAL'),\n",
      " ('15', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': '-form',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'enhancer',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'enhancer',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'Oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '-formulation',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': '-formulation',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'absorption enhancer sodiumN-(8-[2-hydroxy- benzoyl] amino) '\n",
      "            'caprylate (SNAC',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'absorption enhancer sodiumN-(8-[2-hydroxy- benzoyl] amino) '\n",
      "            'caprylate (SNAC',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'gastric',\n",
      "  'target_type': 'BIOLOGICAL_STRUCTURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'gastric',\n",
      "  'source_type': 'BIOLOGICAL_STRUCTURE',\n",
      "  'target': 'Once-daily',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'Once-daily',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'better',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'better',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'glycaemic control',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'glycaemic control',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'reductions',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'reductions',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'body weight',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'body weight',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '26',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': '26',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '-',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': '-',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'week',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'week',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'II',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'II',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '–response',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '–response',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '2 diabetes',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '2 diabetes',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'proteolytic cleavage',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'proteolytic cleavage',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'peptide backbone',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'peptide backbone',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'sequential b-oxidation',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'sequential b-oxidation',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'fatty acid side chain',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'fatty acid side chain',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'subcutaneous',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'subcutaneous',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '12',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': '12',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '13',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': '13',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '26-week',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': '26-week',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '14',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': '14',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '15',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 29 nodes and 28 relationships.\n",
      "graph_35.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('impairment', 'DISEASE_DISORDER'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('renal impair-', 'DISEASE_DISORDER'),\n",
      " ('18', 'DATE'),\n",
      " ('85', 'DATE'),\n",
      " ('years', 'AGE'),\n",
      " ('body mass index', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('18.5–40.0 kg/m2', 'LAB_VALUE'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('creatinine clear-', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Clearance of creatinine', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Cockcroft-Gault formula', 'DETAILED_DESCRIPTION'),\n",
      " ('creatinine', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('adjusted to body surface area calculated by the Dubois and Dubois formula',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('60', 'LAB_VALUE'),\n",
      " ('89 mL/min/1.73 m', 'LAB_VALUE'),\n",
      " ('30', 'LAB_VALUE'),\n",
      " ('59 mL/min/1.73 m', 'LAB_VALUE'),\n",
      " ('severe', 'SEVERITY'),\n",
      " ('impair- ment', 'DISEASE_DISORDER'),\n",
      " ('15', 'LAB_VALUE'),\n",
      " ('29 mL/min/1.73 m 2', 'LAB_VALUE'),\n",
      " ('end-stage renal dis- ease', 'DISEASE_DISORDER'),\n",
      " ('ESRD', 'DISEASE_DISORDER'),\n",
      " ('renal disease', 'DISEASE_DISORDER'),\n",
      " ('haemo', 'HISTORY'),\n",
      " ('dialysis', 'DISEASE_DISORDER'),\n",
      " ('normal', 'LAB_VALUE'),\n",
      " ('renal func- tion', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('good', 'LAB_VALUE'),\n",
      " ('health', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('physical exam', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('vital signs', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('laboratory safety', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('18–85 years', 'DATE'),\n",
      " ('16', 'CARDINAL'),\n",
      " ('serum creatinine', 'ORG'),\n",
      " ('Dubois', 'GPE'),\n",
      " ('17', 'CARDINAL'),\n",
      " ('60–89 mL', 'MONEY'),\n",
      " ('30–59 mL', 'MONEY'),\n",
      " ('15–29 mL', 'MONEY')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'renal impair-',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'renal impair-',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '18',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': '18',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '85',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': '85',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'years',\n",
      "  'target_type': 'AGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'years',\n",
      "  'source_type': 'AGE',\n",
      "  'target': 'body mass index',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'body mass index',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '18.5–40.0 kg/m2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': '18.5–40.0 kg/m2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'creatinine clear-',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'creatinine clear-',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Clearance of creatinine',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'Clearance of creatinine',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Cockcroft-Gault formula',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'Cockcroft-Gault formula',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'creatinine',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'creatinine',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'adjusted to body surface area calculated by the Dubois and Dubois '\n",
      "            'formula',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'adjusted to body surface area calculated by the Dubois and Dubois '\n",
      "            'formula',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': '60',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': '60',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '89 mL/min/1.73 m',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': '89 mL/min/1.73 m',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '30',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': '30',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '59 mL/min/1.73 m',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': '59 mL/min/1.73 m',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'severe',\n",
      "  'target_type': 'SEVERITY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'severe',\n",
      "  'source_type': 'SEVERITY',\n",
      "  'target': 'impair- ment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'impair- ment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '15',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '15',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': '29 mL/min/1.73 m 2',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': '29 mL/min/1.73 m 2',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'end-stage renal dis- ease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'end-stage renal dis- ease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'renal disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'renal disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'haemo',\n",
      "  'target_type': 'HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'haemo',\n",
      "  'source_type': 'HISTORY',\n",
      "  'target': 'dialysis',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'dialysis',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'normal',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'normal',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'renal func- tion',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'renal func- tion',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'good',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'good',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'health',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'health',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'physical exam',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'physical exam',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'vital signs',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'vital signs',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'laboratory safety',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'laboratory safety',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '18–85 years',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '18–85 years',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '16',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '16',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'serum creatinine',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'serum creatinine',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Dubois',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'Dubois',\n",
      "  'source_type': 'GPE',\n",
      "  'target': '17',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '17',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '60–89 mL',\n",
      "  'target_type': 'MONEY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '60–89 mL',\n",
      "  'source_type': 'MONEY',\n",
      "  'target': '30–59 mL',\n",
      "  'target_type': 'MONEY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': '30–59 mL',\n",
      "  'source_type': 'MONEY',\n",
      "  'target': '15–29 mL',\n",
      "  'target_type': 'MONEY'}]\n",
      "Graph created with 44 nodes and 43 relationships.\n",
      "graph_36.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('renal', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('renal transplantation', 'HISTORY'),\n",
      " ('peritoneal dialysis', 'HISTORY'),\n",
      " ('Crohn', 'DISEASE_DISORDER'),\n",
      " ('s disease', 'DISEASE_DISORDER'),\n",
      " ('ulcerative colitis', 'DISEASE_DISORDER'),\n",
      " ('bowel', 'DISEASE_DISORDER'),\n",
      " ('pancreatitis', 'DISEASE_DISORDER'),\n",
      " ('idiopathic', 'DETAILED_DESCRIPTION'),\n",
      " ('medullary thyroid carcinoma', 'FAMILY_HISTORY'),\n",
      " ('type 2', 'DETAILED_DESCRIPTION'),\n",
      " ('multiple', 'FAMILY_HISTORY'),\n",
      " ('endocrine neoplasia syndrome', 'DISEASE_DISORDER'),\n",
      " ('cardiac disease', 'DISEASE_DISORDER'),\n",
      " ('New York', 'DETAILED_DESCRIPTION'),\n",
      " ('Heart', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('Association heart', 'DETAILED_DESCRIPTION'),\n",
      " ('failure', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('functional class III', 'LAB_VALUE'),\n",
      " ('IV', 'LAB_VALUE'),\n",
      " ('myocardial infarction', 'DISEASE_DISORDER'),\n",
      " ('3 months', 'DURATION'),\n",
      " ('angina pectoris', 'DISEASE_DISORDER'),\n",
      " ('hyper- tension', 'SIGN_SYMPTOM'),\n",
      " ('dia', 'DETAILED_DESCRIPTION'),\n",
      " ('stolic', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('blood pressure', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('C 100 mmHg', 'LAB_VALUE'),\n",
      " ('systolic', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('180 mmHg', 'LAB_VALUE'),\n",
      " ('hepatic dysfunction', 'DISEASE_DISORDER'),\n",
      " ('hepatic disease', 'DISEASE_DISORDER'),\n",
      " ('malabsorption', 'DISEASE_DISORDER'),\n",
      " ('renal impairment', 'DISEASE_DISORDER'),\n",
      " ('cimetidine', 'MEDICATION'),\n",
      " ('trimetho- prim', 'MEDICATION'),\n",
      " ('US Food and Drug Administration', 'ORG'),\n",
      " ('FDA', 'ORG'),\n",
      " ('European Medicines Agency', 'ORG'),\n",
      " ('EMA', 'ORG'),\n",
      " ('18', 'CARDINAL'),\n",
      " ('19', 'CARDINAL'),\n",
      " ('Crohn’s', 'PRODUCT'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('neoplasia', 'GPE'),\n",
      " ('New York Heart Association', 'ORG'),\n",
      " ('100', 'CARDINAL'),\n",
      " ('180', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'renal',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'renal transplantation',\n",
      "  'target_type': 'HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'renal transplantation',\n",
      "  'source_type': 'HISTORY',\n",
      "  'target': 'peritoneal dialysis',\n",
      "  'target_type': 'HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'peritoneal dialysis',\n",
      "  'source_type': 'HISTORY',\n",
      "  'target': 'Crohn',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': 'Crohn',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 's disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 's disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'ulcerative colitis',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'ulcerative colitis',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'bowel',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'bowel',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'pancreatitis',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'pancreatitis',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'idiopathic',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'idiopathic',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'medullary thyroid carcinoma',\n",
      "  'target_type': 'FAMILY_HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'medullary thyroid carcinoma',\n",
      "  'source_type': 'FAMILY_HISTORY',\n",
      "  'target': 'type 2',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'type 2',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'multiple',\n",
      "  'target_type': 'FAMILY_HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': 'multiple',\n",
      "  'source_type': 'FAMILY_HISTORY',\n",
      "  'target': 'endocrine neoplasia syndrome',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'endocrine neoplasia syndrome',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'cardiac disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'cardiac disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'New York',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'New York',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Heart',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'Heart',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'Association heart',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'Association heart',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'failure',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'failure',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'functional class III',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'functional class III',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'IV',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'IV',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'myocardial infarction',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'myocardial infarction',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': '3 months',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': '3 months',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'angina pectoris',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'angina pectoris',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'hyper- tension',\n",
      "  'target_type': 'SIGN_SYMPTOM'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'hyper- tension',\n",
      "  'source_type': 'SIGN_SYMPTOM',\n",
      "  'target': 'dia',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'dia',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'stolic',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'stolic',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'blood pressure',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': 'blood pressure',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'C 100 mmHg',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'C 100 mmHg',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'systolic',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': 'systolic',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '180 mmHg',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': '180 mmHg',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'hepatic dysfunction',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'hepatic dysfunction',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'hepatic disease',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'hepatic disease',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'malabsorption',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'malabsorption',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'renal impairment',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': 'renal impairment',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'cimetidine',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'cimetidine',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'trimetho- prim',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'trimetho- prim',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'US Food and Drug Administration',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': 'US Food and Drug Administration',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'FDA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': 'FDA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'European Medicines Agency',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': 'European Medicines Agency',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'EMA',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': 'EMA',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '18',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': '18',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '19',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': '19',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Crohn’s',\n",
      "  'target_type': 'PRODUCT'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'Crohn’s',\n",
      "  'source_type': 'PRODUCT',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'neoplasia',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'neoplasia',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'New York Heart Association',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'New York Heart Association',\n",
      "  'source_type': 'ORG',\n",
      "  'target': '100',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': '100',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '180',\n",
      "  'target_type': 'CARDINAL'}]\n",
      "Graph created with 48 nodes and 47 relationships.\n",
      "graph_37.csv\n",
      "entities: \n",
      "[('lipid-low- ering agents', 'MEDICATION'),\n",
      " ('anti-hypertensive agents', 'MEDICATION'),\n",
      " ('platelet', 'MEDICATION'),\n",
      " ('aggregation', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('inhibitors', 'MEDICATION'),\n",
      " ('aspirin', 'MEDICATION'),\n",
      " ('GLP-1 receptor agonists', 'MEDICATION'),\n",
      " ('DPP-4 inhibitors', 'MEDICATION'),\n",
      " ('multi', 'DETAILED_DESCRIPTION'),\n",
      " ('open-label', 'DETAILED_DESCRIPTION'),\n",
      " ('multiple-dose', 'DETAILED_DESCRIPTION'),\n",
      " ('parallel-', 'DETAILED_DESCRIPTION'),\n",
      " ('oral', 'DETAILED_DESCRIPTION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('Nordisk A/S, Søborg, Denmark', 'DETAILED_DESCRIPTION'),\n",
      " ('10 consecutive days', 'DURATION'),\n",
      " ('5 days', 'DURATION'),\n",
      " ('5 mg', 'DOSAGE'),\n",
      " ('10 mg', 'DOSAGE'),\n",
      " ('semaglutide tablets', 'MEDICATION'),\n",
      " ('300 mg', 'DOSAGE'),\n",
      " ('SNAC', 'MEDICATION'),\n",
      " ('10-day', 'DURATION'),\n",
      " ('lower limit', 'LAB_VALUE'),\n",
      " ('of', 'DETAILED_DESCRIPTION'),\n",
      " ('quantification', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('GLP-1', 'ORG'),\n",
      " ('Ethics Committees', 'GPE'),\n",
      " ('1572', 'DATE'),\n",
      " ('C. Granhall', 'PERSON'),\n",
      " ('Good Clinical Practice', 'ORG'),\n",
      " ('the Declaration of Helsinki', 'WORK_OF_ART'),\n",
      " ('FDA', 'ORG'),\n",
      " ('EMA', 'ORG'),\n",
      " ('18', 'CARDINAL'),\n",
      " ('19', 'CARDINAL'),\n",
      " ('2.1', 'CARDINAL'),\n",
      " ('Novo Nordisk', 'PERSON'),\n",
      " ('Søborg', 'ORG'),\n",
      " ('Denmark', 'GPE'),\n",
      " ('5', 'CARDINAL'),\n",
      " ('10', 'CARDINAL'),\n",
      " ('Fig.1', 'ORG'),\n",
      " ('300', 'CARDINAL'),\n",
      " ('20', 'CARDINAL')]\n",
      "relations: \n",
      "[{'evidence': 'Concomitant use of lipid-lowering agents and aspirin was '\n",
      "              'permitted.',\n",
      "  'relationship': 'Concomitant use of medications',\n",
      "  'source': 'lipid-lowering agents',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'aspirin',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Concomitant use of anti-hypertensive agents and platelet '\n",
      "              'aggregation inhibitors, such as aspirin, was permitted.',\n",
      "  'relationship': 'Concomitant use of medications',\n",
      "  'source': 'anti-hypertensive agents',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'platelet aggregation inhibitors',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Subjects with diabetes, other than those being treated with '\n",
      "              'GLP-1 receptor agonists, could be enrolled in the renally '\n",
      "              'impaired groups.',\n",
      "  'relationship': 'Exclusion criteria',\n",
      "  'source': 'diabetes',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'GLP-1 receptor agonists',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Subjects with diabetes, other than those being treated with '\n",
      "              'DPP-4 inhibitors, could be enrolled in the renally impaired '\n",
      "              'groups.',\n",
      "  'relationship': 'Exclusion criteria',\n",
      "  'source': 'diabetes',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'DPP-4 inhibitors',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Subjects with diabetes being treated with GLP-1 receptor '\n",
      "              'agonists could be enrolled in the renally impaired groups.',\n",
      "  'relationship': 'Treatment condition',\n",
      "  'source': 'GLP-1 receptor agonists',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'renally impaired groups',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Subjects with diabetes being treated with DPP-4 inhibitors '\n",
      "              'could be enrolled in the renally impaired groups.',\n",
      "  'relationship': 'Treatment condition',\n",
      "  'source': 'DPP-4 inhibitors',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'renally impaired groups',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'This was a multicentre trial as described in Trial 1572 C. '\n",
      "              'Granhall et al.',\n",
      "  'relationship': 'Setting',\n",
      "  'source': 'trial 1572 C. Granhall et al.',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': 'multicentre',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'All subjects were treated with oral semaglutide in Trial 1572 '\n",
      "              'C. Granhall et al.',\n",
      "  'relationship': 'Intervention',\n",
      "  'source': 'trial 1572 C. Granhall et al.',\n",
      "  'source_type': 'WORK_OF_ART',\n",
      "  'target': 'oral semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'All subjects were treated with oral semaglutide for 10 '\n",
      "              'consecutive days.',\n",
      "  'relationship': 'Treatment duration',\n",
      "  'source': 'oral semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '10 consecutive days',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'All subjects were treated with oral semaglutide 5 mg for 5 '\n",
      "              'days.',\n",
      "  'relationship': 'Dose administration',\n",
      "  'source': 'oral semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '5 mg',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'All subjects were treated with oral semaglutide 10 mg for 5 '\n",
      "              'days.',\n",
      "  'relationship': 'Dose administration',\n",
      "  'source': 'oral semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '10 mg',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Oral semaglutide tablets included 300 mg of SNAC.',\n",
      "  'relationship': 'Composition',\n",
      "  'source': 'oral semaglutide tablets',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '300 mg of SNAC',\n",
      "  'target_type': 'DOSAGE'}]\n",
      "Graph created with 45 nodes and 12 relationships.\n",
      "graph_38.csv\n",
      "Error in extracting relationships: Expecting value: line 1 column 1 (char 0)\n",
      "entities: \n",
      "[('single tablet', 'DOSAGE'),\n",
      " ('oral', 'ADMINISTRATION'),\n",
      " ('semaglutide', 'MEDICATION'),\n",
      " ('120 mL', 'DOSAGE'),\n",
      " ('water', 'DOSAGE'),\n",
      " ('the morning after overnight fasting', 'DATE'),\n",
      " ('C 6 h', 'DURATION'),\n",
      " ('fluid intake', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('C 2 h before', 'DURATION'),\n",
      " ('food', 'HISTORY'),\n",
      " ('liquid intake', 'HISTORY'),\n",
      " ('30 min', 'DURATION'),\n",
      " ('after', 'DATE'),\n",
      " ('standardised', 'DETAILED_DESCRIPTION'),\n",
      " ('breakfast', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('concomitant medication', 'MEDICATION'),\n",
      " ('within ± 2h', 'DATE'),\n",
      " ('haemodialysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('D', 'DISEASE_DISORDER'),\n",
      " ('three times per week', 'DOSAGE'),\n",
      " ('Haemodial- ysis', 'THERAPEUTIC_PROCEDURE'),\n",
      " ('Fresenius Medical Care (Bad Homburg, Germany) machine',\n",
      "  'DETAILED_DESCRIPTION'),\n",
      " ('B Braun (Hessen, Germany) Dialog/C210machine', 'DETAILED_DESCRIPTION'),\n",
      " ('Xevonta low flux membrane', 'DETAILED_DESCRIPTION'),\n",
      " ('high flux membrane', 'DETAILED_DESCRIPTION'),\n",
      " ('blood flow rate', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('500–600 mL/min', 'LAB_VALUE'),\n",
      " ('ultrafiltration rate', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('0–23 mL/min', 'LAB_VALUE'),\n",
      " ('Blood samples', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('aglutide', 'DIAGNOSTIC_PROCEDURE'),\n",
      " ('time', 'DETAILED_DESCRIPTION'),\n",
      " ('until', 'DATE'),\n",
      " ('504 h (21 days', 'DATE'),\n",
      " ('the morning', 'TIME'),\n",
      " ('overnight', 'TIME'),\n",
      " ('6', 'CARDINAL'),\n",
      " ('2', 'CARDINAL'),\n",
      " ('30', 'CARDINAL'),\n",
      " ('2h', 'CARDINAL'),\n",
      " ('ESRD', 'ORG'),\n",
      " ('three', 'CARDINAL'),\n",
      " ('two', 'CARDINAL'),\n",
      " ('Fresenius Medical Care (', 'ORG'),\n",
      " ('Germany', 'GPE'),\n",
      " ('B Braun (Hessen', 'ORG'),\n",
      " ('Xevonta', 'GPE'),\n",
      " ('Lo 15', 'LAW'),\n",
      " ('15 or Hi 18', 'DATE'),\n",
      " ('500–600 mL', 'QUANTITY'),\n",
      " ('mL', 'PERSON'),\n",
      " ('504', 'CARDINAL'),\n",
      " ('21 days', 'DATE')]\n",
      "relations: \n",
      "[{'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO',\n",
      "  'source': 'single tablet',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'oral',\n",
      "  'target_type': 'ADMINISTRATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Measured as',\n",
      "  'source': 'oral',\n",
      "  'source_type': 'ADMINISTRATION',\n",
      "  'target': 'semaglutide',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_STUDY',\n",
      "  'source': 'semaglutide',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': '120 mL',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED_IN',\n",
      "  'source': '120 mL',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'water',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARED_WITH',\n",
      "  'source': 'water',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'the morning after overnight fasting',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILARITY',\n",
      "  'source': 'the morning after overnight fasting',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'C 6 h',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SUPERVISOR',\n",
      "  'source': 'C 6 h',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'fluid intake',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SIMILAR_WITH',\n",
      "  'source': 'fluid intake',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'C 2 h before',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PREDISPOSES_TO',\n",
      "  'source': 'C 2 h before',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'food',\n",
      "  'target_type': 'HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURRED_DURING_TRIAL',\n",
      "  'source': 'food',\n",
      "  'source_type': 'HISTORY',\n",
      "  'target': 'liquid intake',\n",
      "  'target_type': 'HISTORY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONVERSION_EQUATION',\n",
      "  'source': 'liquid intake',\n",
      "  'source_type': 'HISTORY',\n",
      "  'target': '30 min',\n",
      "  'target_type': 'DURATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Restricted from',\n",
      "  'source': '30 min',\n",
      "  'source_type': 'DURATION',\n",
      "  'target': 'after',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEAN_CHANGE',\n",
      "  'source': 'after',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'standardised',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_USED_FOR',\n",
      "  'source': 'standardised',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'breakfast',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'AFFECTS',\n",
      "  'source': 'breakfast',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'concomitant medication',\n",
      "  'target_type': 'MEDICATION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TIMEPOINT',\n",
      "  'source': 'concomitant medication',\n",
      "  'source_type': 'MEDICATION',\n",
      "  'target': 'within ± 2h',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Therapeutic Effect',\n",
      "  'source': 'within ± 2h',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'haemodialysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INDICATES',\n",
      "  'source': 'haemodialysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'D',\n",
      "  'target_type': 'DISEASE_DISORDER'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INVOLVED IN',\n",
      "  'source': 'D',\n",
      "  'source_type': 'DISEASE_DISORDER',\n",
      "  'target': 'three times per week',\n",
      "  'target_type': 'DOSAGE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'IS_PART_OF',\n",
      "  'source': 'three times per week',\n",
      "  'source_type': 'DOSAGE',\n",
      "  'target': 'Haemodial- ysis',\n",
      "  'target_type': 'THERAPEUTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_GRANTS_FROM',\n",
      "  'source': 'Haemodial- ysis',\n",
      "  'source_type': 'THERAPEUTIC_PROCEDURE',\n",
      "  'target': 'Fresenius Medical Care (Bad Homburg, Germany) machine',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_VALUE',\n",
      "  'source': 'Fresenius Medical Care (Bad Homburg, Germany) machine',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'B Braun (Hessen, Germany) Dialog/C210machine',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'EXTENDS_TO',\n",
      "  'source': 'B Braun (Hessen, Germany) Dialog/C210machine',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'Xevonta low flux membrane',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Employee of',\n",
      "  'source': 'Xevonta low flux membrane',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'high flux membrane',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLICATION_OF',\n",
      "  'source': 'high flux membrane',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'blood flow rate',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'RECEIVED_FEES_FROM',\n",
      "  'source': 'blood flow rate',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '500–600 mL/min',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPARISON_WITH_MEDICATION',\n",
      "  'source': '500–600 mL/min',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'ultrafiltration rate',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DOES_NOT_DEPEND_ON',\n",
      "  'source': 'ultrafiltration rate',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': '0–23 mL/min',\n",
      "  'target_type': 'LAB_VALUE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'TREATED_WITH',\n",
      "  'source': '0–23 mL/min',\n",
      "  'source_type': 'LAB_VALUE',\n",
      "  'target': 'Blood samples',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'added to',\n",
      "  'source': 'Blood samples',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'aglutide',\n",
      "  'target_type': 'DIAGNOSTIC_PROCEDURE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'OCCURS_DURING',\n",
      "  'source': 'aglutide',\n",
      "  'source_type': 'DIAGNOSTIC_PROCEDURE',\n",
      "  'target': 'time',\n",
      "  'target_type': 'DETAILED_DESCRIPTION'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COMPLETED_TRIAL_TREATMENT',\n",
      "  'source': 'time',\n",
      "  'source_type': 'DETAILED_DESCRIPTION',\n",
      "  'target': 'until',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'MEASUREMENT_FROM',\n",
      "  'source': 'until',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '504 h (21 days',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'SPONSORED_BY',\n",
      "  'source': '504 h (21 days',\n",
      "  'source_type': 'DATE',\n",
      "  'target': 'the morning',\n",
      "  'target_type': 'TIME'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_CATEGORY',\n",
      "  'source': 'the morning',\n",
      "  'source_type': 'TIME',\n",
      "  'target': 'overnight',\n",
      "  'target_type': 'TIME'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'DERIVED_FROM',\n",
      "  'source': 'overnight',\n",
      "  'source_type': 'TIME',\n",
      "  'target': '6',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDED_AS',\n",
      "  'source': '6',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDED_TO',\n",
      "  'source': '2',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '30',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'PUBLICATION_DATE',\n",
      "  'source': '30',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '2h',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSE_OF_DISCONTINUATION',\n",
      "  'source': '2h',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'ESRD',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'BASELINE_MEASUREMENT',\n",
      "  'source': 'ESRD',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'three',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'ADDITIONAL THERAPY',\n",
      "  'source': 'three',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'two',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'HAS_DOSE_AT_WEEK',\n",
      "  'source': 'two',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': 'Fresenius Medical Care (',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCREASED_WITH',\n",
      "  'source': 'Fresenius Medical Care (',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Germany',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CAUSES',\n",
      "  'source': 'Germany',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'B Braun (Hessen',\n",
      "  'target_type': 'ORG'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES_AS_COVARIATE',\n",
      "  'source': 'B Braun (Hessen',\n",
      "  'source_type': 'ORG',\n",
      "  'target': 'Xevonta',\n",
      "  'target_type': 'GPE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'Received personal fees from',\n",
      "  'source': 'Xevonta',\n",
      "  'source_type': 'GPE',\n",
      "  'target': 'Lo 15',\n",
      "  'target_type': 'LAW'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'CONTROL_GROUP',\n",
      "  'source': 'Lo 15',\n",
      "  'source_type': 'LAW',\n",
      "  'target': '15 or Hi 18',\n",
      "  'target_type': 'DATE'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'COLLABORATOR',\n",
      "  'source': '15 or Hi 18',\n",
      "  'source_type': 'DATE',\n",
      "  'target': '500–600 mL',\n",
      "  'target_type': 'QUANTITY'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'NOT_RELATED_TO_TREATMENT',\n",
      "  'source': '500–600 mL',\n",
      "  'source_type': 'QUANTITY',\n",
      "  'target': 'mL',\n",
      "  'target_type': 'PERSON'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'publishes',\n",
      "  'source': 'mL',\n",
      "  'source_type': 'PERSON',\n",
      "  'target': '504',\n",
      "  'target_type': 'CARDINAL'},\n",
      " {'evidence': 'Fallback relationship based on entity proximity',\n",
      "  'relationship': 'INCLUDES',\n",
      "  'source': '504',\n",
      "  'source_type': 'CARDINAL',\n",
      "  'target': '21 days',\n",
      "  'target_type': 'DATE'}]\n",
      "Graph created with 53 nodes and 52 relationships.\n",
      "graph_39.csv\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "from typing import List, Tuple, Dict\n",
    "from transformers import pipeline\n",
    "from openai import OpenAI\n",
    "from pprint import pprint\n",
    "import spacy\n",
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "from neo4j import GraphDatabase\n",
    "from dotenv import load_dotenv\n",
    "from configurations import ALL_RELATIONS\n",
    "\n",
    "load_dotenv()\n",
    "\n",
    "# Load environment variables\n",
    "API_KEY = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "\n",
    "\n",
    "# Initialize NER model\n",
    "def load_ner_model(model_name: str):\n",
    "    return pipeline(\n",
    "        \"token-classification\",\n",
    "        model=model_name,\n",
    "        aggregation_strategy=\"simple\"\n",
    "    )\n",
    "\n",
    "# Load spaCy model\n",
    "def load_spacy_model():\n",
    "    try:\n",
    "        return spacy.load(\"en_core_web_sm\")\n",
    "    except OSError:\n",
    "        print(\"Downloading spaCy language model...\")\n",
    "        spacy.cli.download(\"en_core_web_sm\")\n",
    "        return spacy.load(\"en_core_web_sm\")\n",
    "\n",
    "# Extract entities using both models\n",
    "def extract_entities(text: str, ner_model, nlp) -> List[Tuple[str, str]]:\n",
    "    ner_results = ner_model(text)\n",
    "    entities = [(res[\"word\"], res[\"entity_group\"]) for res in ner_results]\n",
    "    \n",
    "    doc = nlp(text)\n",
    "    spacy_entities = [(ent.text, ent.label_) for ent in doc.ents]\n",
    "    \n",
    "    all_entities = entities + spacy_entities\n",
    "    unique_entities = []\n",
    "    seen = set()\n",
    "    for entity, entity_type in all_entities:\n",
    "        if entity.lower() not in seen:\n",
    "            unique_entities.append((entity, entity_type))\n",
    "            seen.add(entity.lower())\n",
    "    \n",
    "    # print('entity: ',unique_entities)\n",
    "    return unique_entities\n",
    "\n",
    "# Generate relationships using OpenAI\n",
    "def generate_relations(text: str, entities: List[Tuple[str, str]], openai_client, openai_model: str) -> List[Dict]:\n",
    "    entities_str = \"\\n\".join([\n",
    "        f\"{idx+1}. {entity} (Type: {entity_type})\"\n",
    "        for idx, (entity, entity_type) in enumerate(entities)\n",
    "    ])\n",
    "    \n",
    "    prompt = f\"\"\"\n",
    "        You are an expert pharmalogy researcher. You are given a text and a list of entities extracted from the text. Help the user to identify all possible relationships between the entities to prepare a knowledge graph. You can also suggest new entities that are not mentioned in the text but are important to understand the text.\n",
    " \n",
    "        ### Text Context:\n",
    "        {text}\n",
    " \n",
    "        ### Extracted Entities:\n",
    "        {entities_str}\n",
    " \n",
    "        ### Guidelines:\n",
    "        1. Use context to identify all relationships between entities, providing evidence from the text.\n",
    "        2. Output relationships in JSON format, as shown below:\n",
    "        [\n",
    "            {{\n",
    "                \"source\": \"Entity1\",\n",
    "                \"source_type\": \"Type1\",\n",
    "                \"target\": \"Entity2\",\n",
    "                \"target_type\": \"Type2\",\n",
    "                \"relationship\": \"RELATIONSHIP_TYPE\",\n",
    "                \"evidence\": \"Evidence from the text\"\n",
    "            }},\n",
    "            ...\n",
    "        ]\n",
    "    \"\"\"\n",
    "\n",
    "    try:\n",
    "        response = openai_client.chat.completions.create(\n",
    "            model=openai_model,\n",
    "            messages=[\n",
    "                {\"role\": \"system\", \"content\": \"You are a medical relationship extraction expert.\"},\n",
    "                {\"role\": \"user\", \"content\": prompt}\n",
    "            ],\n",
    "            max_tokens=1500,\n",
    "            temperature=0.7\n",
    "        )\n",
    "        raw_content = response.choices[0].message.content.strip()\n",
    "      \n",
    "        # Parse the response to ensure it's valid JSON\n",
    "        relations = json.loads(raw_content)\n",
    "        \n",
    "\n",
    "\n",
    "        if not isinstance(relations, list):\n",
    "            raise ValueError(\"Response is not a valid list of relationships.\")\n",
    "        return relations\n",
    "\n",
    "    except Exception as e:\n",
    "        print(f\"Error in extracting relationships: {e}\")\n",
    "        return generate_fallback_relations(entities)\n",
    "\n",
    "\n",
    "\n",
    "def generate_fallback_relations(entities: List[Tuple[str, str]]) -> List[Dict]:\n",
    "    fallback_relations = []\n",
    "    relationship_types = ALL_RELATIONS\n",
    "    for i in range(len(entities) - 1):\n",
    "        source, source_type = entities[i]\n",
    "        target, target_type = entities[i + 1]\n",
    "        fallback_relations.append({\n",
    "            \"source\": source,\n",
    "            \"source_type\": source_type,\n",
    "            \"target\": target,\n",
    "            \"target_type\": target_type,\n",
    "            \"relationship\": relationship_types[i % len(relationship_types)],\n",
    "            \"evidence\": \"Fallback relationship based on entity proximity\"\n",
    "        })\n",
    "    return fallback_relations\n",
    "\n",
    "\n",
    "def create_neo4j_graph(uri: str, username: str, password: str, entities: List[Tuple[str, str]], relations: List[Dict]):\n",
    "    driver = GraphDatabase.driver(uri, auth=(username, password))\n",
    "    with driver.session() as session:\n",
    "        try:\n",
    "            # Add nodes and relationships\n",
    "            session.execute_write(create_nodes, entities)\n",
    "            session.execute_write(create_relationships, relations)\n",
    "            print(f\"Graph created with {len(entities)} nodes and {len(relations)} relationships.\")\n",
    "        finally:\n",
    "            driver.close()\n",
    "\n",
    "\n",
    "def create_nodes(tx, entities):\n",
    "    for entity, entity_type in entities:\n",
    "        tx.run(\n",
    "            \"MERGE (n:Entity {name: $name, type: $type})\",\n",
    "            {\"name\": entity, \"type\": entity_type}\n",
    "        )\n",
    "\n",
    "def create_relationships(tx, relations):\n",
    "    \"\"\"\n",
    "    Create relationships in Neo4j with specific types.\n",
    "    \"\"\"\n",
    "    for relation in relations:\n",
    "        relationship_type = relation[\"relationship\"].replace(\" \", \"_\").upper()  # Ensure valid Neo4j relationship format\n",
    "        \n",
    "        # Ensure the relationship type is dynamically inserted safely\n",
    "        query = \"\"\"\n",
    "        MATCH (source:Entity {name: $source})\n",
    "        MATCH (target:Entity {name: $target})\n",
    "        MERGE (source)-[r:`%s`]->(target)\n",
    "        SET r.evidence = $evidence\n",
    "        \"\"\" % relationship_type  # Insert the dynamic relationship type safely\n",
    "        \n",
    "        tx.run(query, {\n",
    "            \"source\": relation[\"source\"],\n",
    "            \"target\": relation[\"target\"],\n",
    "            \"evidence\": relation.get(\"evidence\", \"No specific evidence\")\n",
    "        })\n",
    "\n",
    "\n",
    "\n",
    "def clear_neo4j_database(uri: str, username: str, password: str):\n",
    "    \"\"\"\n",
    "    Deletes all nodes and relationships from the Neo4j database.\n",
    "    \"\"\"\n",
    "    driver = GraphDatabase.driver(uri, auth=(username, password))\n",
    "    with driver.session() as session:\n",
    "        try:\n",
    "            session.run(\"MATCH (n) DETACH DELETE n\")\n",
    "            print(\"Neo4j database cleared successfully.\")\n",
    "        finally:\n",
    "            driver.close()\n",
    "\n",
    "\n",
    "def process_text(text: str, ner_model, nlp, openai_client, openai_model, neo4j_config):\n",
    "    entities = extract_entities(text, ner_model, nlp)\n",
    "    relations = generate_relations(text, entities, openai_client, openai_model)\n",
    "    print('entities: ')\n",
    "    pprint(entities)\n",
    "    print('relations: ')\n",
    "    pprint(relations)\n",
    "    create_neo4j_graph(\n",
    "        uri=neo4j_config[\"uri\"],\n",
    "        username=neo4j_config[\"username\"],\n",
    "        password=neo4j_config[\"password\"],\n",
    "        entities=entities,\n",
    "        relations=relations\n",
    "    )\n",
    "   \n",
    "    return entities, relations\n",
    "\n",
    "def export_graph_to_csv(uri: str, username: str, password: str, output_file: str):\n",
    "    \"\"\"\n",
    "    Export the entire Neo4j graph to a CSV file.\n",
    "    \"\"\"\n",
    "    driver = GraphDatabase.driver(uri, auth=(username, password))\n",
    "    query = \"\"\"\n",
    "    CALL apoc.export.csv.all($filePath, {useTypes: true, quotes: true})\n",
    "    \"\"\"\n",
    "    with driver.session() as session:\n",
    "        session.run(query, {\"filePath\": output_file})\n",
    "        print(f\"Graph exported to {output_file}.\")\n",
    "    driver.close()\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    text_file_path = 'data/sample.txt'\n",
    "    neo4j_url=\"bolt://localhost:7687\"\n",
    "    neo4j_username=\"neo4j\"\n",
    "    neo4j_password=\"123456789\"\n",
    "    ner_model=\"Clinical-AI-Apollo/Medical-NER\"\n",
    "    OPEN_AI_MODEL='gpt-3.5-turbo'\n",
    "\n",
    "\n",
    "    # with open(text_file_path, 'r', encoding='utf-8') as f:\n",
    "    #     text = f.read()\n",
    "\n",
    "    ner_model = load_ner_model(ner_model)\n",
    "    nlp = load_spacy_model()\n",
    "    openai_client = OpenAI(api_key=API_KEY)\n",
    "    neo4j_config = {\n",
    "        \"uri\": neo4j_url,\n",
    "        \"username\": neo4j_username,\n",
    "        \"password\": neo4j_password\n",
    "    }\n",
    "    clear_neo4j_database(neo4j_config[\"uri\"], neo4j_config[\"username\"], neo4j_config[\"password\"])\n",
    "    # process_text(text, ner_model, nlp, openai_client, OPEN_AI_MODEL, neo4j_config)\n",
    "\n",
    "\n",
    "    \n",
    "    paper_text_dir='paper_16_paragraphs'\n",
    "    # text_files=[ os.path.join(paper_text_dir,file) for file  in os.listdir(paper_text_dir)]\n",
    "    text_files=[ paper_text_dir+'/'+file for file  in os.listdir(paper_text_dir)]\n",
    "    # print(text_files)\n",
    "    \n",
    "\n",
    "    \n",
    "    for idx, text_file in enumerate(text_files):\n",
    "    # Process the text file\n",
    "        db_name = f\"db_{idx + 1}\"\n",
    "        neo4j_config = {\n",
    "            \"uri\": neo4j_url,\n",
    "            \"username\": neo4j_username,\n",
    "            \"password\": neo4j_password,\n",
    "            \"database\": db_name\n",
    "        }\n",
    "        with open(text_file, 'r', encoding='utf-8') as f:\n",
    "            text = f.read()\n",
    "        \n",
    "        \n",
    "        process_text(text, ner_model, nlp, openai_client, OPEN_AI_MODEL, neo4j_config=neo4j_config)\n",
    "\n",
    "        # Export the graph\n",
    "        output_file = f\"graph_{idx + 1}.csv\"\n",
    "        print(output_file)\n",
    "        # export_graph_to_csv(neo4j_config[\"uri\"], neo4j_config[\"username\"], neo4j_config[\"password\"], output_file)\n",
    "   \n",
    "\n",
    "\n",
    "\n",
    "    \n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "NER",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
